Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2017);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Publisher;Coverage;Categories
1;20425;Nature Reviews Drug Discovery;journal;14741776;10.106;Q1;289;211;710;7107;7161;321;17.86;33.68;United Kingdom;Nature Publishing Group;2002-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
2;21191;Pharmacological Reviews;journal;15210081, 00316997;9.472;Q1;210;19;87;6570;1856;83;19.67;345.79;United States;American Society for Pharmacology and Experimental Therapeutics;1949-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
3;4700152457;Nano Today;journal;17480132;7.191;Q1;119;47;185;6310;2529;135;17.15;134.26;Netherlands;Elsevier BV;2006-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
4;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;6.718;Q1;193;28;91;3720;1239;90;13.94;132.86;United States;Annual Reviews Inc.;1965-1973, 1975-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
5;22321;Trends in Pharmacological Sciences;journal;01656147;4.794;Q1;201;95;279;7600;2762;227;11.49;80.00;Netherlands;Elsevier BV;1979-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
6;19409;Advanced Drug Delivery Reviews;journal;0169409X;4.09;Q1;278;146;508;24626;6753;464;13.85;168.67;Netherlands;Elsevier BV;1987-ongoing;Pharmaceutical Science (Q1)
7;21195;Pharmacology and Therapeutics;journal;01637258;4.072;Q1;180;142;358;25171;3921;356;10.34;177.26;United Kingdom;Elsevier Ltd.;1975-1977, 1979-1985, 1987-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
8;12611;Drug Resistance Updates;journal;13687646, 15322084;3.986;Q1;100;17;64;2472;754;63;12.21;145.41;United States;Churchill Livingstone;1998-ongoing;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
9;26371;Natural Product Reports;journal;02650568, 14604752;3.918;Q1;157;63;253;11363;2531;239;10.53;180.37;United Kingdom;Royal Society of Chemistry;1984-ongoing;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
10;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;3.388;Q1;194;283;937;33967;6261;911;6.96;120.02;Switzerland;Birkhauser Verlag;1997-ongoing;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
11;18017;Neuropsychopharmacology;journal;0893133X;3.327;Q1;204;289;990;16215;5893;916;6.39;56.11;United Kingdom;Nature Publishing Group;1987-ongoing;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
12;21100456838;Cell Chemical Biology;journal;24519448, 24519456;3.174;Q1;166;180;562;8100;2976;532;4.87;45.00;United States;Elsevier Inc.;2016-ongoing;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
13;12455;Molecular Therapy;journal;15250024, 15250016;3.141;Q1;158;263;718;11825;4003;553;7.21;44.96;United States;Cell Press;2000-ongoing;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
14;21100853576;Bulletin of Faculty of Pharmacy, Cairo University;journal;11100931;3.075;Q1;1;0;1;0;18;1;0;0.00;Egypt;Faculty of Pharmacy, Cairo University;2014;"Pharmaceutical Science (Q1); Pharmacy (Q1)"
15;19907;Medicinal Research Reviews;journal;01986325, 10981128;2.895;Q1;119;38;109;9057;1070;108;8.72;238.34;United States;John Wiley & Sons Inc.;1981-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
16;21100466864;Journal for ImmunoTherapy of Cancer;journal;20511426;2.798;Q1;36;99;219;4071;1315;193;6.63;41.12;United Kingdom;BioMed Central;2014-ongoing;"Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Molecular Medicine (Q1); Oncology (Q1); Pharmacology (Q1)"
17;21100777378;Therapeutic Advances in Vaccines;journal;20510136;2.769;Q1;5;0;6;0;61;6;0;0.00;United States;SAGE Publications Inc.;2014-2015;"Drug Discovery (Q1); Immunology (Q1); Immunology and Allergy (Q1); Oncology (Q1); Pharmacology (medical) (Q1)"
18;19700178100;Nanotechnology, Science and Applications;journal;11778903;2.723;Q1;23;15;17;689;241;16;13.3;45.93;New Zealand;Dove Medical Press Ltd.;2010-2012, 2014-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
19;23010;Journal of Controlled Release;journal;01683659;2.684;Q1;237;508;1596;34844;13107;1492;8.07;68.59;Netherlands;Elsevier BV;1984-ongoing;Pharmaceutical Science (Q1)
20;18148;Pain;journal;03043959;2.671;Q1;238;336;1103;15802;5270;854;5.8;47.03;United States;Lippincott Williams & Wilkins Ltd.;1975-ongoing;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
21;20084;British Journal of Pharmacology;journal;00071188;2.603;Q1;190;359;1137;32971;6963;1104;6.83;91.84;United States;Wiley-Blackwell;1958, 1965-ongoing;Pharmacology (Q1)
22;11900154404;PLoS Neglected Tropical Diseases;journal;19352727, 19352735;2.589;Q1;110;906;2569;43586;11650;2424;4.61;48.11;United States;Public Library of Science;2007-ongoing;"Infectious Diseases (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1)"
23;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;2.567;Q1;240;708;2292;37587;14773;2220;6.5;53.09;United States;American Chemical Society;1963-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1)"
24;5100155080;Neurotherapeutics;journal;19337213;2.53;Q1;100;101;246;9014;1419;220;5.97;89.25;United States;Springer New York LLC;2007-ongoing;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
25;21100218543;Molecular Therapy - Nucleic Acids;journal;21622531;2.523;Q1;43;162;257;8806;1457;238;5.52;54.36;United States;Cell Press;2012-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1)"
26;21100207003;Theranostics;journal;18387640;2.515;Q1;69;366;400;20906;3701;393;8.99;57.12;Canada;Ivyspring International Publisher;2012-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
27;20681;Current Opinion in Pharmacology;journal;14714892;2.504;Q1;120;115;331;6188;1846;303;6.81;53.81;Netherlands;Elsevier BV;2001-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
28;21100232818;Emerging Microbes and Infections;journal;22221751;2.433;Q1;31;115;187;2792;885;148;5.76;24.28;United Kingdom;Nature Publishing Group;2012-ongoing;"Drug Discovery (Q1); Epidemiology (Q1); Immunology (Q1); Infectious Diseases (Q1); Medicine (miscellaneous) (Q1); Microbiology (Q1); Parasitology (Q1); Virology (Q1)"
29;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;2.419;Q1;172;561;1680;15726;7783;1412;5.4;28.03;United Kingdom;Oxford University Press;1975-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
30;144771;Clinical Trials;journal;17407753, 17407745;2.399;Q1;55;85;280;2327;632;222;2.76;27.38;United States;SAGE Publications;2004-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
31;19700174891;Perspectives in Medicinal Chemistry;journal;1177391X;2.374;Q1;13;0;11;0;116;10;4.8;0.00;New Zealand;Libertas Academica;2008-2011, 2014-ongoing;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
32;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2.291;Q1;232;955;3298;32722;14645;3060;4.52;34.26;United States;American Society for Microbiology;1963-1970, 1972-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
33;19600166320;Protein & Cell;journal;16748018, 1674800X;2.286;Q1;48;108;319;4860;1268;254;4.95;45.00;Germany;Springer Verlag;2010-ongoing;"Biochemistry (Q1); Biotechnology (Q1); Cell Biology (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1)"
34;21100850730;npj Vaccines;journal;20590105;2.269;Q1;8;36;16;1896;43;15;2.87;52.67;United Kingdom;Nature Publishing Group;2016-ongoing;"Immunology (Q1); Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
35;4400151524;Particle and Fibre Toxicology;journal;17438977;2.253;Q1;83;54;178;3258;1514;171;6.55;60.33;United Kingdom;BioMed Central;2004-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
36;15984;Journal of Molecular Medicine;journal;09462716, 14321440;2.177;Q1;127;129;379;7032;1761;338;5.09;54.51;Germany;Springer Verlag;1976-1978, 1980-1981, 1995-ongoing;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
37;19963;Molecular Pharmacology;journal;15210111, 0026895X;2.076;Q1;186;136;527;6779;2112;498;4.07;49.85;United States;American Society for Pharmacology and Experimental Therapeutics;1965-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
38;20435;Neuropharmacology;journal;00283908;2.043;Q1;150;452;1234;35570;5924;1214;4.42;78.69;United Kingdom;Elsevier Ltd.;1962-ongoing;"Pharmacology (Q1); Cellular and Molecular Neuroscience (Q2)"
39;21196;Drug Discovery Today;journal;13596446;2.008;Q1;157;193;642;14814;3909;609;7.08;76.76;Netherlands;Elsevier BV;1996-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
40;21165;PharmacoEconomics;journal;11707690;1.998;Q1;91;117;327;5353;1185;273;4.2;45.75;United Kingdom;Adis International Ltd.;1992-ongoing;"Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1)"
41;21100225611;Advanced healthcare materials;journal;21922640, 21922659;1.989;Q1;63;302;837;22886;4620;781;5.69;75.78;United Kingdom;John Wiley and Sons Ltd;2012-ongoing;"Biomaterials (Q1); Biomedical Engineering (Q1); Pharmaceutical Science (Q1)"
42;24749;Addiction Biology;journal;13556215, 13691600;1.952;Q1;70;155;297;8490;1274;293;4.65;54.77;United States;Wiley-Blackwell;1996-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
43;23109;Journal of Psychopharmacology;journal;02698811;1.939;Q1;106;158;414;10619;1673;375;4.81;67.21;United States;SAGE Publications;1987-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
44;19617;Antiviral Research;journal;01663542;1.925;Q1;108;251;602;11224;2723;583;4.61;44.72;Netherlands;Elsevier BV;1959, 1981-ongoing;"Pharmacology (Q1); Virology (Q1)"
45;15576;European Neuropsychopharmacology;journal;0924977X;1.911;Q1;100;129;625;7137;2601;600;4.22;55.33;Netherlands;Elsevier BV;1990-ongoing;"Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Biological Psychiatry (Q2)"
46;20063;Biochemical Pharmacology;journal;00062952;1.832;Q1;181;284;858;20819;4085;757;4.62;73.31;Netherlands;Elsevier BV;1958-ongoing;"Biochemistry (Q1); Pharmacology (Q1)"
47;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;1.828;Q1;98;38;121;4759;735;115;5.51;125.24;United Kingdom;Taylor & Francis;1971-ongoing;Toxicology (Q1)
48;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1.816;Q1;70;23;46;3288;312;45;6.83;142.96;United Kingdom;Taylor & Francis;1998-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
49;21169;Pharmacological Research;journal;10436618, 10961186;1.811;Q1;118;298;736;24548;3636;683;5.22;82.38;United States;Elsevier Inc.;1989-ongoing;Pharmacology (Q1)
50;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;1.808;Q1;93;116;549;6663;2270;523;4.41;57.44;United Kingdom;Oxford University Press;1998-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
51;16876;Bioconjugate Chemistry;journal;15204812, 10431802;1.801;Q1;161;328;872;16008;3982;844;4.66;48.80;United States;American Chemical Society;1990-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
52;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;1.794;Q1;61;38;124;1457;358;119;2.58;38.34;United States;Mary Ann Liebert Inc.;2011-ongoing;"Biochemistry (Q1); Drug Discovery (Q1); Genetics (Q1); Molecular Medicine (Q1); Molecular Biology (Q2)"
53;20700195026;Acta Pharmaceutica Sinica B;journal;22113843, 22113835;1.793;Q1;28;83;158;3905;926;143;6.45;47.05;Netherlands;Elsevier BV;2014-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
54;4000148406;Clinical Toxicology;journal;15563650;1.792;Q1;85;162;443;3067;1523;298;5.03;18.93;United Kingdom;Taylor & Francis;1968-1998, 2005-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
55;4000149101;Nanomedicine: Nanotechnology, Biology, and Medicine;journal;15499634, 15499642;1.743;Q1;106;251;600;12225;3919;581;6.98;48.71;Netherlands;Elsevier BV;2005-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
56;26380;Drug and Alcohol Dependence;journal;03768716;1.715;Q1;151;461;1298;22575;4630;1255;3.51;48.97;Netherlands;Elsevier BV;1975-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
57;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;02785846;1.714;Q1;114;190;502;13395;2209;487;4.42;70.50;Netherlands;Elsevier BV;1982-ongoing;"Pharmacology (Q1); Biological Psychiatry (Q2)"
58;20626;Clinical Pharmacology and Therapeutics;journal;00099236;1.699;Q1;173;241;565;7505;2616;506;5.05;31.14;United States;Wiley-Blackwell;1960-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
59;21100335701;Vaccines;journal;2076393X;1.691;Q1;24;51;141;3816;714;137;5.46;74.82;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2014-ongoing;"Drug Discovery (Q1); Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Immunology (Q2)"
60;5400152706;Nanotoxicology;journal;17435390, 17435404;1.63;Q1;72;101;366;5726;2303;355;5.98;56.69;United Kingdom;Informa Healthcare;2007-ongoing;"Biomedical Engineering (Q1); Nanoscience and Nanotechnology (Q1); Toxicology (Q1)"
61;23916;Environmental Pollution;journal;02697491, 18736424;1.615;Q1;194;1101;1910;62371;9894;1865;4.68;56.65;United Kingdom;Elsevier Ltd.;1970-1980, 1986-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
62;19700175015;Infection and Drug Resistance;journal;11786973;1.603;Q1;27;60;109;2252;505;105;4.19;37.53;New Zealand;Dove Medical Press Ltd;2009-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
63;21354;Expert Opinion on Therapeutic Targets;journal;14728222;1.597;Q1;78;109;372;10784;1593;361;4.39;98.94;United Kingdom;Taylor & Francis;1997-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
64;21100214102;Frontiers in Pharmacology;journal;16639812;1.587;Q1;62;951;1108;59672;4567;1021;4.06;62.75;Switzerland;Frontiers Media S.A.;2010-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
65;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.586;Q1;209;198;743;9383;2829;702;3.88;47.39;United States;American Society for Pharmacology and Experimental Therapeutics;1945-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
66;22477;Investigational New Drugs;journal;01676997, 15730646;1.573;Q1;80;99;379;2990;1451;372;3.72;30.20;Netherlands;Kluwer Academic Publishers;1983-ongoing;"Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
67;130126;Molecular Pharmaceutics;journal;15438384, 15438392;1.572;Q1;110;442;1273;21243;6410;1254;4.82;48.06;United States;American Chemical Society;2004-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmaceutical Science (Q1)"
68;4000148203;Handbook of Experimental Pharmacology;book series;01712004;1.57;Q1;81;151;329;15468;1303;246;5.83;102.44;Germany;Springer Verlag;2005-ongoing;"Biochemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
69;21100197941;International Journal for Parasitology: Drugs and Drug Resistance;journal;22113207;1.556;Q1;27;46;108;2240;423;106;3.29;48.70;Netherlands;Elsevier BV;2011-ongoing;"Infectious Diseases (Q1); Parasitology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
70;20783;Expert Review of Vaccines;journal;14760584;1.551;Q1;75;112;419;9099;1432;392;3.77;81.24;United Kingdom;Taylor & Francis;2002-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1); Immunology (Q2)"
71;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;1.543;Q1;131;303;849;11268;3153;732;4.1;37.19;United Kingdom;Blackwell Publishing Inc.;1974-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
72;24604;Archives of Toxicology;journal;14320738, 03405761;1.541;Q1;96;303;627;17861;3132;524;5.86;58.95;Germany;Springer Verlag;1972-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
73;25218;Toxicological Sciences;journal;10960929, 10966080;1.538;Q1;164;264;797;13112;3434;729;4.55;49.67;United Kingdom;Oxford University Press;1981-ongoing;Toxicology (Q1)
74;19427;Advances in Pharmacology;book series;10543589;1.536;Q1;68;36;118;5802;432;0;0;161.17;United States;Elsevier Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
75;19700174913;Therapeutic Advances in Neurological Disorders;journal;17562864, 17562856;1.522;Q1;40;34;103;1851;478;96;5.33;54.44;United Kingdom;SAGE Publications;2008-ongoing;"Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
76;145164;Human Genomics;journal;14739542, 14797364;1.501;Q1;49;35;90;1643;316;84;3.83;46.94;United Kingdom;BioMed Central;2003-2006, 2008-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1); Genetics (Q2); Molecular Biology (Q2)"
77;21124;Pharmaceutical Statistics;journal;15391612, 15391604;1.494;Q1;33;43;163;1094;194;156;0.95;25.44;United States;John Wiley & Sons Inc.;2004-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Statistics and Probability (Q1)"
78;21782;Psychopharmacology;journal;00333158;1.494;Q1;181;301;1206;18788;3801;1129;3.3;62.42;Germany;Springer Verlag;1959-ongoing;Pharmacology (Q1)
79;20624;Clinical Pharmacokinetics;journal;03125963;1.482;Q1;150;124;313;7053;1367;275;4.61;56.88;United Kingdom;Adis International Ltd.;1976-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
80;24032;Reviews of Physiology Biochemistry and Pharmacology;book series;03034240;1.463;Q1;58;3;26;524;110;17;7;174.67;Germany;Springer Verlag;1974-2008, 2012-ongoing;"Biochemistry (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q1); Physiology (medical) (Q2)"
81;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1.449;Q1;143;228;957;11605;2872;901;3.15;50.90;United States;Wiley-Blackwell;1977-ongoing;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
82;21237;Drug Safety;journal;01145916;1.447;Q1;115;119;324;4822;1123;267;4.03;40.52;United Kingdom;Adis International Ltd.;1990-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
83;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1.433;Q1;161;161;719;6281;2633;679;3.68;39.01;United States;American Society for Pharmacology and Experimental Therapeutics;1973-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
84;84948;Expert Opinion on Drug Delivery;journal;17425247;1.432;Q1;88;122;431;10421;2220;410;5.4;85.42;United Kingdom;Taylor & Francis;2004-ongoing;Pharmaceutical Science (Q1)
85;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;1.424;Q1;102;126;395;6960;1614;384;4.06;55.24;Netherlands;Kluwer Academic Publishers;1996-ongoing;"Biochemistry (medical) (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Cancer Research (Q2); Cell Biology (Q2)"
86;4700152903;Forensic Toxicology;journal;18608965, 18608973;1.407;Q1;30;45;131;1394;418;122;3.99;30.98;Germany;Springer Verlag;2006-ongoing;"Biochemistry (medical) (Q1); Pathology and Forensic Medicine (Q1); Toxicology (Q1)"
87;19700177127;ACS Medicinal Chemistry Letters;journal;19485875;1.388;Q1;52;240;684;5964;2450;664;3.84;24.85;United States;American Chemical Society;2010-ongoing;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
88;11700154316;CNS Neuroscience and Therapeutics;journal;17555949, 17555930;1.38;Q1;59;101;406;4533;1303;318;3.77;44.88;United States;Wiley-Blackwell;2008-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Physiology (medical) (Q2)"
89;16088;Journal of Nanobiotechnology;journal;14773155;1.38;Q1;57;92;234;5120;1364;229;5.54;55.65;United Kingdom;BioMed Central;2003-ongoing;"Applied Microbiology and Biotechnology (Q1); Bioengineering (Q1); Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Nanoscience and Nanotechnology (Q2)"
90;4700152872;Journal of NeuroImmune Pharmacology;journal;15571890, 15571904;1.379;Q1;64;60;190;4115;661;184;3.45;68.58;Germany;Springer Verlag;2006-ongoing;"Pharmacology (Q1); Immunology (Q2); Immunology and Allergy (Q2); Neuroscience (miscellaneous) (Q2)"
91;24786;Alcohol and Alcoholism;journal;07350414, 14643502;1.376;Q1;89;115;323;3389;857;292;2.28;29.47;United Kingdom;Oxford University Press;1965-ongoing;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
92;110112;Journal of immunotherapy (Hagerstown, Md. : 1997);journal;15249557;1.373;Q1;89;44;140;1337;519;138;4.14;30.39;United States;Lippincott Williams & Wilkins Ltd.;1994-ongoing;"Pharmacology (Q1); Cancer Research (Q2); Immunology (Q2); Immunology and Allergy (Q2)"
93;23053;Journal of Natural Products;journal;01633864, 15206025;1.368;Q1;124;430;1210;15248;4710;1178;4.04;35.46;United States;American Chemical Society;1949, 1971, 1973, 1978-ongoing;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
94;19700175029;Pharmacogenomics and Personalized Medicine;journal;11787066;1.353;Q1;22;31;66;1481;301;64;4.18;47.77;New Zealand;Dove Medical Press Ltd;2009-ongoing;"Pharmacology (Q1); Molecular Medicine (Q2)"
95;22378;Vascular Pharmacology;journal;15371891;1.352;Q1;86;52;321;3195;1162;314;3.73;61.44;Netherlands;Elsevier BV;2002-ongoing;"Pharmacology (Q1); Molecular Medicine (Q2); Physiology (Q2)"
96;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;1.349;Q1;63;62;211;3322;542;174;3.01;53.58;Netherlands;Kluwer Academic Publishers;1987-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
97;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1.346;Q1;81;86;251;3416;742;242;2.92;39.72;United Kingdom;Nature Publishing Group;2006-ongoing;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
98;19700174905;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;journal;11787007;1.342;Q1;35;52;164;2713;621;161;3.22;52.17;New Zealand;Dove Medical Press Ltd.;2009-ongoing;"Internal Medicine (Q1); Pharmacology (Q1)"
99;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;09396411;1.342;Q1;138;268;822;12856;4023;811;4.83;47.97;Netherlands;Elsevier BV;1991-ongoing;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
100;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;1.32;Q1;78;88;231;3686;860;228;3.65;41.89;United Kingdom;Nature Publishing Group;2001-ongoing;"Pharmacology (Q1); Genetics (Q2); Molecular Medicine (Q2)"
101;6800153101;Expert Opinion on Drug Discovery;journal;1746045X, 17460441;1.309;Q1;50;107;311;10857;1169;295;4.5;101.47;United Kingdom;Informa Healthcare;2006-ongoing;Drug Discovery (Q1)
102;28792;Cancer Biology and Therapy;journal;15384047;1.3;Q1;101;130;556;4853;1821;533;3.48;37.33;United States;Landes Bioscience;2002-ongoing;"Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2); Oncology (Q2)"
103;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;1.294;Q1;43;88;255;1675;208;242;0.58;19.03;United States;Marcel Dekker Inc.;1991-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Statistics and Probability (Q2)"
104;17700156714;Pharmaceuticals;journal;14248247;1.293;Q1;44;95;177;6229;766;167;4.17;65.57;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2009-ongoing;"Pharmaceutical Science (Q1); Molecular Medicine (Q2)"
105;24763;Addictive Behaviors;journal;03064603;1.29;Q1;114;324;888;13440;2765;878;2.72;41.48;United Kingdom;Elsevier Ltd.;1975-ongoing;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
106;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.275;Q1;153;285;872;14871;3498;862;3.96;52.18;United States;Elsevier Inc.;1959-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
107;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484;1.272;Q1;44;64;175;3550;502;169;2.71;55.47;United States;SAGE Publications;1996-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
108;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1.271;Q1;89;21;98;3158;492;97;4.07;150.38;United States;Marcel Dekker Inc.;1972-ongoing;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
109;17464;European Journal of Medicinal Chemistry;journal;02235234;1.266;Q1;135;902;2419;47362;11535;2406;4.89;52.51;Netherlands;Elsevier BV;1974-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Organic Chemistry (Q1); Pharmacology (Q1)"
110;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.266;Q1;116;125;362;4774;930;328;2.56;38.19;United States;Center of Alcohol Studies, Rutgers, The State University of New Jersey;2007-ongoing;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
111;21455;Progress in Medicinal Chemistry;book series;00796468;1.253;Q1;33;5;17;525;58;4;8;105.00;Netherlands;Elsevier BV;1961-1963, 1965, 1967, 1969-ongoing;"Pharmacology (Q1); Molecular Medicine (Q2)"
112;21100819608;Emerging Contaminants;journal;24056650, 24056642;1.233;Q1;9;17;35;1007;114;33;3.45;59.24;China;KeAi Communications Co;2015-ongoing;"Health, Toxicology and Mutagenesis (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1)"
113;7700153108;International journal of nanomedicine;journal;11782013, 11769114;1.225;Q1;100;636;1592;31660;7900;1554;4.6;49.78;New Zealand;Dove Medical Press Ltd;2006-ongoing;"Bioengineering (Q1); Biomaterials (Q1); Biophysics (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Organic Chemistry (Q1); Nanoscience and Nanotechnology (Q2)"
114;14990;Current Neuropharmacology;journal;1570159X;1.21;Q1;58;86;244;9570;879;213;3.58;111.28;United Arab Emirates;Bentham Science Publishers;2004-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Neurology (Q2); Neurology (clinical) (Q2)"
115;19900192174;International Journal of Applied Pharmaceutics;journal;09757058;1.209;Q1;9;161;49;3309;66;49;1.49;20.55;India;International Journal of Applied Pharmaceutics;2011-ongoing;Pharmaceutical Science (Q1)
116;4700152848;PPAR Research;journal;16874757, 16874765;1.204;Q1;40;26;91;1851;279;87;3.35;71.19;Egypt;Hindawi Publishing Corporation;2006-ongoing;"Drug Discovery (Q1); Pharmacology (medical) (Q1)"
117;4700152278;Drugs in Context;journal;17404398, 17451981;1.194;Q1;12;11;39;359;125;37;3.13;32.64;United Kingdom;BioExcel Publishing Ltd;2006-2008, 2012-ongoing;"Pharmacology (Q1); Molecular Medicine (Q2)"
118;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;1.191;Q1;67;54;138;3145;401;133;2.9;58.24;Netherlands;Elsevier BV;1996, 1998-ongoing;"Pharmacology (Q1); Biochemistry (Q2); Physiology (Q2); Cell Biology (Q3)"
119;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.187;Q1;144;196;675;14439;2527;652;3.61;73.67;United States;American Chemical Society;1988-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
120;21100209501;Statistics in Biopharmaceutical Research;journal;19466315;1.187;Q1;11;44;114;925;88;100;0.81;21.02;United Kingdom;Taylor and Francis Inc.;2011-ongoing;"Pharmaceutical Science (Q1); Statistics and Probability (Q2)"
121;14144;Experimental and Clinical Psychopharmacology;journal;10641297;1.176;Q1;82;57;163;3054;418;160;2.53;53.58;United States;American Psychological Association;1993-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
122;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;1.173;Q1;78;152;494;7511;1594;482;3.49;49.41;United States;Nature Publishing Group;1980-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
123;22454;International Journal of Pharmaceutics;journal;03785173;1.172;Q1;190;875;2514;43949;10697;2474;4.11;50.23;Netherlands;Elsevier BV;1978-ongoing;Pharmaceutical Science (Q1)
124;19700173005;Cancer Nanotechnology;journal;18686958, 18686966;1.168;Q1;19;10;23;861;101;20;3.92;86.10;United States;Springer Science + Business Media;2010-ongoing;"Biomedical Engineering (Q1); Pharmaceutical Science (Q1); Physical and Theoretical Chemistry (Q1); Oncology (Q2)"
125;21351;Expert Opinion on Investigational Drugs;journal;13543784;1.166;Q1;94;140;406;10495;1348;388;3.69;74.96;United Kingdom;Taylor & Francis;1994-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
126;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;1.159;Q1;99;205;553;6456;1544;486;2.96;31.49;Germany;Springer Verlag;1968-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
127;24785;Alcohol;journal;07418329;1.153;Q1;74;84;248;4784;701;239;2.51;56.95;Netherlands;Elsevier BV;1984-ongoing;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1); Behavioral Neuroscience (Q2); Biochemistry (Q2); Neurology (Q2)"
128;29712;Clinical Therapeutics;journal;01492918;1.151;Q1;123;227;762;8718;2093;661;3.2;38.41;United States;Elsevier Inc.;1977-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
129;23015;Journal of Ethnopharmacology;journal;03788741;1.15;Q1;170;453;2114;26219;7622;2079;3.38;57.88;Netherlands;Elsevier BV;1979-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
130;21197;Pharmacology Biochemistry and Behavior;journal;00913057;1.15;Q1;126;123;602;8333;1870;587;2.75;67.75;United States;Elsevier Inc.;1973-ongoing;"Clinical Biochemistry (Q1); Pharmacology (Q1); Toxicology (Q1); Behavioral Neuroscience (Q2); Biochemistry (Q2); Biological Psychiatry (Q3)"
131;29097;Cancer Chemotherapy and Pharmacology;journal;03445704;1.147;Q1;100;268;857;8689;2569;829;3.01;32.42;Germany;Springer Verlag;1978-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2)"
132;25096;Food and Chemical Toxicology;journal;02786915;1.144;Q1;149;597;1112;33536;4656;1062;4.11;56.17;Netherlands;Elsevier BV;1982-ongoing;"Food Science (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
133;14500154702;Journal of Cardiovascular Translational Research;journal;19375395, 19375387;1.141;Q1;44;54;205;2295;457;196;2.2;42.50;United States;Springer New York LLC;2008-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Pharmaceutical Science (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Medicine (Q2)"
134;4400151608;ChemMedChem;journal;18607187, 18607179;1.137;Q1;92;235;878;10687;2295;842;2.66;45.48;Germany;Wiley - V C H Verlag GmbbH & Co.;2006-ongoing;"Organic Chemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q2)"
135;16573;Phytotherapy Research;journal;10991573, 0951418X;1.136;Q1;112;202;732;10691;2782;718;3.61;52.93;United States;John Wiley & Sons Inc.;1987-ongoing;Pharmacology (Q1)
136;17700156705;Modern Trends in Pharmacopsychiatry;book series;16622685;1.12;Q1;10;13;13;1282;43;12;3.58;98.62;Switzerland;Karger;2009-2010, 2013-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
137;19700175143;Pharmacognosy Reviews;journal;09737847, 09762787;1.12;Q1;36;22;64;2165;319;62;3.16;98.41;India;Medknow Publications;2009-ongoing;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Plant Science (Q1); Pharmacology (Q2)"
138;4000148019;AAPS Journal;journal;15507416;1.118;Q1;96;175;437;9199;1644;416;3.71;52.57;United States;Springer New York;1999-ongoing;Pharmaceutical Science (Q1)
139;13250;Expert Opinion on Biological Therapy;journal;14712598;1.117;Q1;75;148;488;12513;1544;461;3.77;84.55;United Kingdom;Taylor & Francis;2001-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q2)"
140;19700174974;Future Medicinal Chemistry;journal;17568919, 17568927;1.111;Q1;54;160;534;10039;1554;440;3.47;62.74;United Kingdom;Future Medicine Ltd.;2009-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q2); Pharmacology (Q2)"
141;21000196010;Topics in antiviral medicine;journal;21615853;1.11;Q2;37;16;60;250;178;57;2.98;15.63;United States;International Antiviral Society;2011-ongoing;"Pharmacology (medical) (Q1); Infectious Diseases (Q2); Pharmacology (Q2); Virology (Q2)"
142;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;1.109;Q2;43;28;130;3050;380;121;3.59;108.93;United Kingdom;Taylor & Francis;2000-ongoing;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
143;25240;Toxicology Letters;journal;03784274;1.103;Q1;129;240;908;10914;3187;867;3.26;45.48;Netherlands;Elsevier BV;1977-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
144;25219;Toxicology;journal;0300483X;1.1;Q1;143;196;460;11505;1609;442;3.43;58.70;Netherlands;Elsevier BV;1959, 1973-ongoing;Toxicology (Q1)
145;17067;Phytomedicine;journal;09447113;1.087;Q1;105;174;603;6574;2333;586;3.98;37.78;Netherlands;Elsevier BV;1994-ongoing;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Pharmacology (Q2)"
146;21123;Pharmaceutical Research;journal;07248741, 1573904X;1.077;Q1;191;246;855;11699;3011;833;3.65;47.56;United States;Kluwer Academic/Plenum Publishers;1984-ongoing;"Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
147;11900154314;Cardiovascular Therapeutics;journal;17555914, 17555922;1.075;Q2;39;74;154;2776;392;149;2.36;37.51;United States;Wiley-Blackwell;2008-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
148;17595;Journal of Biomolecular Screening;journal;10870571;1.074;Q1;69;13;389;436;920;376;2.46;33.54;United States;Sage Science Press;1996-ongoing;"Analytical Chemistry (Q1); Biotechnology (Q1); Drug Discovery (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
149;20578;Journal of Food and Drug Analysis;journal;10219498;1.071;Q2;41;108;277;5098;1119;271;3.18;47.20;Taiwan;Elsevier Taiwan LLC;1994-ongoing;"Food Science (Q1); Pharmacology (Q2)"
150;20473;Life Sciences;journal;00243205;1.071;Q1;150;339;1267;17945;4131;1242;3.39;52.94;Netherlands;Elsevier BV;1962-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
151;25125;Journal of Analytical Toxicology;journal;01464760;1.065;Q1;69;109;343;2645;843;313;2.64;24.27;United States;Perston Publications, Inc.;1977-ongoing;"Analytical Chemistry (Q1); Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Environmental Chemistry (Q2)"
152;21100469670;Antibiotics;journal;20796382;1.063;Q1;20;39;116;2276;340;112;2.78;58.36;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2014-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry (Q2); Infectious Diseases (Q2); Microbiology (Q2); Microbiology (medical) (Q2); Pharmacology (medical) (Q2)"
153;18071;Neurotoxicity Research;journal;10298428;1.063;Q1;65;115;247;6892;763;242;3.06;59.93;United States;Springer New York LLC;2001-ongoing;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
154;22410;Inflammation Research;journal;1420908X, 10233830;1.062;Q2;82;103;316;5701;942;312;2.88;55.35;Switzerland;Birkhauser Verlag;1995-ongoing;"Immunology (Q2); Pharmacology (Q2)"
155;21333;European Journal of Pharmacology;journal;00142999;1.057;Q2;167;540;2001;27806;6551;1971;3.28;51.49;Netherlands;Elsevier BV;1967-ongoing;Pharmacology (Q2)
156;21100197929;Toxicological Research;journal;19768257;1.052;Q1;20;40;129;1574;402;125;2.81;39.35;South Korea;Korean Association of Medical Journal Editors;2008-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
157;22432;International Immunopharmacology;journal;15675769;1.051;Q2;98;363;1308;15145;4231;1279;3.25;41.72;Netherlands;Elsevier BV;2001-ongoing;"Immunology (Q2); Immunology and Allergy (Q2); Pharmacology (Q2)"
158;21100370879;Journal of managed care & specialty pharmacy;journal;23761032, 23760540;1.048;Q1;55;148;390;4046;837;358;1.98;27.34;United States;Academy of Managed Care Pharmacy (AMCP);2014-ongoing;"Health Policy (Q1); Pharmaceutical Science (Q1); Pharmacy (Q1)"
159;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;1.04;Q1;61;142;594;6429;2024;590;3.61;45.27;United Kingdom;Taylor & Francis;1985-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
160;20051;BioDrugs;journal;11738804;1.038;Q2;60;47;139;3085;507;127;4.44;65.64;United Kingdom;Adis International Ltd.;1997-ongoing;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
161;19984;Assay and Drug Development Technologies;journal;1540658X;1.033;Q1;52;36;191;1221;409;138;2.06;33.92;United States;Mary Ann Liebert Inc.;2002-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q2)"
162;24652;Chemico-Biological Interactions;journal;00092797;1.033;Q2;108;286;914;13670;3223;889;3.48;47.80;Netherlands;Elsevier BV;1969-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
163;18073;NeuroToxicology;journal;0161813X;1.017;Q2;102;186;437;9946;1455;414;3.16;53.47;Netherlands;Elsevier BV;1979-ongoing;"Neuroscience (miscellaneous) (Q2); Toxicology (Q2)"
164;21331;European Journal of Pharmaceutical Sciences;journal;09280987;1.016;Q1;119;506;849;24359;3340;831;3.67;48.14;Netherlands;Elsevier BV;1993-ongoing;Pharmaceutical Science (Q1)
165;23488;Current Medicinal Chemistry;journal;09298673;1.015;Q2;158;287;880;34023;2792;820;3.43;118.55;United Arab Emirates;Bentham Science Publishers;1994-ongoing;"Molecular Medicine (Q2); Pharmacology (Q2)"
166;21100825823;Pharmacology Research and Perspectives;journal;20521707;1.005;Q1;20;86;233;3468;659;228;2.99;40.33;United Kingdom;Wiley-Blackwell Publishing Ltd;2013-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Neurology (Q2)"
167;26767;Altex;journal;1868596X, 18688551;1.001;Q2;45;42;137;2436;511;114;4.35;58.00;Germany;Spektrum Akademischer Verlag GmbH;2000-ongoing;"Medical Laboratory Technology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
168;22983;Journal of Clinical Pharmacology;journal;00912700;0.997;Q2;106;184;554;6257;1534;512;3.03;34.01;United States;Wiley-Blackwell;1961-1964, 1970-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
169;19600166302;Current molecular pharmacology;journal;18744702;0.996;Q1;34;28;90;2372;161;75;2.15;84.71;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q2); Pharmacology (Q2)"
170;18075;Neurotoxicology and Teratology;journal;08920362;0.987;Q2;89;67;229;4140;658;209;3.03;61.79;Netherlands;Elsevier BV;1987-ongoing;"Developmental Neuroscience (Q2); Toxicology (Q2); Cellular and Molecular Neuroscience (Q3)"
171;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;0.986;Q2;74;97;405;3169;1057;401;2.8;32.67;Netherlands;Elsevier BV;1996-ongoing;"Molecular Medicine (Q2); Pharmacology (Q2)"
172;21100200427;Human Vaccines and Immunotherapeutics;journal;21645515, 2164554X;0.984;Q2;43;441;1404;17109;2848;1117;2.48;38.80;United States;Landes Bioscience;2012-ongoing;"Medicine (miscellaneous) (Q1); Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
173;23079;Journal of Pharmaceutical Sciences;journal;00223549;0.984;Q1;159;413;1303;17916;4061;1236;3.33;43.38;United States;Elsevier Inc.;1961-ongoing;Pharmaceutical Science (Q1)
174;21100781436;Journal of Experimental Pharmacology;journal;11791454;0.981;Q2;7;9;13;501;25;13;1.75;55.67;New Zealand;Dove Medical Press Ltd.;2010, 2013-ongoing;"Molecular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
175;144790;Marine Drugs;journal;16603397;0.978;Q1;84;393;961;22484;4557;952;4.8;57.21;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2005-ongoing;Drug Discovery (Q1)
176;19700175230;Drug Design, Development and Therapy;journal;11778881;0.974;Q1;48;330;1149;15141;3500;1102;3.1;45.88;New Zealand;Dove Medical Press Ltd;2007-ongoing;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)"
177;19300156901;Dose-Response;journal;15593258;0.959;Q2;30;43;104;1812;344;99;2.79;42.14;United States;International Dose-Response Society;2008-ongoing;"Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q2)"
178;21790;Antiviral Therapy;journal;13596535;0.958;Q2;78;92;313;2597;648;299;2.07;28.23;United Kingdom;International Medical Press;1996-ongoing;"Infectious Diseases (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
179;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0.958;Q2;76;154;471;8261;1591;467;3.14;53.64;United States;John Wiley & Sons Inc.;1981-ongoing;Toxicology (Q2)
180;19034;Microbial Drug Resistance;journal;10766294;0.957;Q2;62;138;278;5253;671;275;2.32;38.07;United States;Mary Ann Liebert Inc.;1995-ongoing;"Medicine (miscellaneous) (Q1); Microbiology (Q2); Microbiology (medical) (Q2); Pharmacology (Q2); Immunology (Q3)"
181;19700188352;Toxins;journal;20726651;0.955;Q2;56;410;904;24575;3135;871;3.42;59.94;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2010-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
182;4700152856;Expert Opinion on Drug Metabolism and Toxicology;journal;17425255;0.954;Q2;72;121;421;10053;1327;400;3.27;83.08;United Kingdom;Informa Healthcare;2005-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Toxicology (Q2)"
183;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0.952;Q2;70;90;270;5110;760;270;2.96;56.78;Poland;Polish Physiological Society;1991-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q2)"
184;28620;Biomedicine and Pharmacotherapy;journal;07533322;0.951;Q2;78;1628;1181;82524;4094;1173;3.55;50.69;France;Elsevier Masson;1982-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
185;29311;Current Cancer Drug Targets;journal;15680096;0.951;Q1;85;72;224;7154;574;205;2.48;99.36;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Pharmacology (Q2); Cancer Research (Q3)"
186;22072;Current Gene Therapy;journal;15665232;0.951;Q1;65;44;142;4205;293;131;2.22;95.57;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Genetics (Q2); Molecular Medicine (Q2); Genetics (clinical) (Q3); Molecular Biology (Q3)"
187;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412711;0.95;Q1;61;46;153;1870;436;147;3.02;40.65;United States;Mary Ann Liebert Inc.;2008-ongoing;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q2); Pulmonary and Respiratory Medicine (Q2)"
188;19700188360;Pharmaceutics;journal;19994923;0.949;Q1;32;59;106;3237;406;101;3.79;54.86;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2010-ongoing;Pharmaceutical Science (Q1)
189;18800156730;Biomolecules and Therapeutics;journal;19769148, 20054483;0.946;Q1;26;79;227;3841;668;222;2.8;48.62;South Korea;Korean Society of Applied Pharmacology;2008-ongoing;"Drug Discovery (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
190;19700182043;Drug Delivery and Translational Research;journal;21903948, 2190393X;0.944;Q1;27;80;171;3948;563;162;3.55;49.35;Germany;Springer verlag;2011-ongoing;Pharmaceutical Science (Q1)
191;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;0.941;Q1;89;88;278;4266;794;273;2.44;48.48;Netherlands;Kluwer Academic Publishers;1987-ongoing;"Computer Science Applications (Q1); Drug Discovery (Q1); Physical and Theoretical Chemistry (Q2)"
192;18077;Fitoterapia;journal;0367326X;0.937;Q1;90;186;724;5934;2170;720;2.88;31.90;Netherlands;Elsevier BV;1948-1949, 1961, 1972-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
193;21100853016;Antibodies;journal;20734468;0.931;Q2;5;2;14;117;37;14;3;58.50;Switzerland;MDPI AG;2014-ongoing;"Drug Discovery (Q2); Immunology and Allergy (Q2); Immunology (Q3)"
194;25224;Toxicology in Vitro;journal;08872333;0.931;Q2;96;254;668;12268;2349;657;3.5;48.30;Netherlands;Elsevier BV;1987-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
195;21353;Expert Opinion on Therapeutic Patents;journal;13543776;0.926;Q2;61;106;329;8792;975;323;2.75;82.94;United Kingdom;Taylor & Francis;1991-ongoing;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
196;21100258853;F1000Research;journal;20461402;0.926;Q1;32;739;1327;37578;2496;1240;2.1;50.85;United Kingdom;F1000 Research Ltd.;2012-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Immunology and Microbiology (miscellaneous)  (Q2)"
197;22411;Inflammopharmacology;journal;09254692, 15685608;0.925;Q2;45;64;111;3470;351;105;3.43;54.22;Switzerland;Birkhauser Verlag;1991-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2); Immunology (Q3)"
198;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0.924;Q2;56;41;92;2890;446;85;5.95;70.49;Netherlands;Kluwer Academic Publishers;1984-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Cell Biology (Q3)"
199;4200151509;Molecular Diagnosis and Therapy;journal;11771062;0.923;Q2;34;65;188;4237;474;181;2.82;65.18;United Kingdom;Adis International Ltd.;2006-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
200;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085;0.919;Q1;114;605;1687;18809;5319;1672;3.02;31.09;Netherlands;Elsevier BV;1983-ongoing;"Analytical Chemistry (Q1); Pharmaceutical Science (Q1); Spectroscopy (Q1); Clinical Biochemistry (Q2); Drug Discovery (Q2)"
201;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;0.917;Q2;91;102;431;4838;1001;409;2.35;47.43;United States;Lippincott Williams & Wilkins Ltd.;1979-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
202;20049;Behavioural Pharmacology;journal;14735849, 09558810;0.916;Q2;76;68;253;4155;535;246;1.91;61.10;United States;Lippincott Williams & Wilkins Ltd.;1992-ongoing;"Pharmacology (Q2); Psychiatry and Mental Health (Q2)"
203;18966;Mutagenesis;journal;02678357, 14643804;0.916;Q2;82;57;223;2086;590;219;2.74;36.60;United Kingdom;Oxford University Press;1986-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Genetics (Q3); Genetics (clinical) (Q3)"
204;21352;Expert Opinion on Pharmacotherapy;journal;14656566;0.909;Q2;69;208;754;14584;2124;710;3.16;70.12;United Kingdom;Taylor & Francis;1999-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
205;20664;Current Drug Targets;journal;13894501;0.906;Q2;92;144;543;14497;1283;487;2.38;100.67;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Clinical Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
206;19900192163;Results in Pharma Sciences;journal;22112863;0.904;Q1;13;0;10;0;38;10;5.25;0.00;Netherlands;Elsevier BV;2011-ongoing;Pharmaceutical Science (Q1)
207;14805;Steroids;journal;0039128X;0.904;Q2;95;136;570;5197;1502;551;2.64;38.21;Netherlands;Elsevier BV;1963-ongoing;"Biochemistry (Q2); Clinical Biochemistry (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Endocrinology (Q3); Molecular Biology (Q3)"
208;4700151922;Research in Social and Administrative Pharmacy;journal;15517411;0.897;Q1;37;144;279;4891;631;218;2.59;33.97;Netherlands;Elsevier BV;2005-ongoing;"Pharmaceutical Science (Q1); Pharmacy (Q1)"
209;21100225613;Human gene therapy methods;journal;19466536, 19466544;0.894;Q2;20;33;88;1386;206;85;2.44;42.00;United States;Mary Ann Liebert Inc.;2012-ongoing;"Applied Microbiology and Biotechnology (Q2); Pharmacology (Q2); Genetics (Q3); Genetics (clinical) (Q3); Molecular Medicine (Q3)"
210;25151;Journal of Toxicology and Environmental Health - Part A;journal;10872620, 15287394;0.888;Q2;80;123;362;6243;1006;357;2.84;50.76;United Kingdom;Taylor & Francis;1996-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
211;12331;Current Topics in Medicinal Chemistry;journal;15680266;0.885;Q2;104;266;749;27281;2118;651;3.45;102.56;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
212;19700174958;Drug Testing and Analysis;journal;19427611, 19427603;0.884;Q1;44;201;448;6896;1317;410;2.99;34.31;United Kingdom;John Wiley & Sons Ltd.;2009-ongoing;"Analytical Chemistry (Q1); Pharmaceutical Science (Q1); Spectroscopy (Q1); Environmental Chemistry (Q2)"
213;20682;Current Pharmaceutical Design;journal;13816128;0.883;Q2;140;612;1837;73255;4992;1673;2.84;119.70;United Arab Emirates;Bentham Science Publishers;1995-ongoing;"Drug Discovery (Q2); Pharmacology (Q2)"
214;25898;Journal of Peptide Science;journal;10752617, 10991387;0.883;Q2;60;102;317;4773;680;308;2.05;46.79;United States;John Wiley & Sons Inc.;1995-ongoing;"Biochemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Biology (Q3); Molecular Medicine (Q3); Structural Biology (Q3)"
215;21264;Drugs in R and D;journal;11745886;0.881;Q2;39;65;113;2742;276;107;3.01;42.18;United Kingdom;Adis International Ltd.;1999, 2002-2008, 2010-ongoing;Pharmacology (Q2)
216;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;0.871;Q1;142;677;2142;27762;6376;2093;3.01;41.01;United Kingdom;Elsevier Ltd.;1993-ongoing;"Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Biology (Q3); Molecular Medicine (Q3)"
217;21100241624;International Journal of Genomics;journal;2314436X, 23144378;0.868;Q1;17;82;167;4472;439;160;1.81;54.54;Egypt;Hindawi Publishing Corporation;2013-ongoing;"Pharmaceutical Science (Q1); Biochemistry (Q2); Genetics (Q3); Molecular Biology (Q3)"
218;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;0.863;Q2;78;126;507;9916;1117;437;2.1;78.70;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Neuroscience (miscellaneous) (Q3)"
219;26370;Molecules;journal;14203049;0.855;Q1;116;2301;4456;115106;15057;4402;3.25;50.02;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);1996-ongoing;"Analytical Chemistry (Q1); Chemistry (miscellaneous) (Q1); Pharmaceutical Science (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Molecular Medicine (Q3)"
220;23014;Journal of Drug Targeting;journal;10292330, 1061186X;0.851;Q1;80;91;274;5585;827;264;3.37;61.37;United Kingdom;Taylor & Francis;1986-1987, 1992-ongoing;Pharmaceutical Science (Q1)
221;25789;Bioorganic Chemistry;journal;00452068, 10902120;0.85;Q2;50;186;285;7928;1075;280;4.04;42.62;United States;Elsevier Inc.;1971-ongoing;"Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
222;19700174906;Molecular and Cellular Pharmacology;journal;19381247;0.846;Q1;21;3;10;33;19;8;1.8;11.00;United States;Lumitext Publishing;2009-ongoing;"Pharmaceutical Science (Q1); Molecular Biology (Q3)"
223;24028;Reproductive Toxicology;journal;08906238;0.846;Q2;99;190;488;11609;1289;462;2.8;61.10;Netherlands;Elsevier BV;1987-ongoing;Toxicology (Q2)
224;21167;Pharmacogenomics;journal;14622416;0.845;Q2;83;163;562;8194;1268;522;2.27;50.27;United Kingdom;Ashley Publications Ltd.;2000-ongoing;"Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
225;21100793213;Current Pharmacology Reports;journal;2198641X;0.844;Q2;13;39;76;4191;230;76;3.03;107.46;Switzerland;Springer International Publishing AG;2015, 2017-ongoing;"Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2); Genetics (Q3)"
226;19700194010;MedChemComm;journal;20402503, 20402511;0.843;Q1;44;233;760;10325;1801;718;2.41;44.31;United Kingdom;Royal Society of Chemistry;2010-ongoing;"Pharmaceutical Science (Q1); Biochemistry (Q2)"
227;110172;Progress in Drug Research;book series;0071786X;0.843;Q1;38;24;64;1745;97;26;1.86;72.71;Switzerland;Birkhauser Verlag;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3)"
228;16533;Phytochemical Analysis;journal;09580344, 10991565;0.841;Q2;63;65;164;2117;445;163;2.6;32.57;United States;John Wiley & Sons Inc.;1990-ongoing;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Food Science (Q1); Plant Science (Q1); Biochemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3)"
229;22575;Cardiovascular Toxicology;journal;15307905;0.836;Q2;47;58;127;2098;342;123;2.68;36.17;United States;Humana Press, Inc.;2001-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Toxicology (Q2); Molecular Biology (Q3)"
230;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298;0.836;Q2;83;128;381;5808;891;360;2.48;45.38;Germany;Springer Verlag;1969-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
231;20663;Current Drug Metabolism;journal;13892002;0.833;Q2;97;103;229;9577;714;214;2.9;92.98;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Clinical Biochemistry (Q2); Pharmacology (Q2)"
232;10300153301;Expert Review of Clinical Pharmacology;journal;17512433;0.833;Q1;32;132;318;10330;806;296;2.63;78.26;United Kingdom;Taylor & Francis;2008-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
233;11700154733;Journal of Biomedical Nanotechnology;journal;15507033;0.828;Q1;64;148;607;9058;2957;606;5.32;61.20;United States;American Scientific Publishers;2007-ongoing;"Materials Science (miscellaneous) (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Medicine (miscellaneous) (Q2); Nanoscience and Nanotechnology (Q2)"
234;21207;Drug Discovery Today: Technologies;journal;17406749;0.822;Q2;41;29;106;1225;247;94;2.54;42.24;Netherlands;Elsevier BV;2004-ongoing;"Biotechnology (Q2); Drug Discovery (Q2); Molecular Medicine (Q3)"
235;19400157146;Food Additives and Contaminants: Part B Surveillance;journal;19393210, 19393229;0.82;Q2;21;41;146;1465;333;145;2.43;35.73;United Kingdom;Taylor & Francis;2008-ongoing;"Food Science (Q1); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
236;25109;Inhalation Toxicology;journal;08958378, 10917691;0.814;Q2;77;64;242;3029;500;238;1.93;47.33;United Kingdom;Taylor & Francis;1989-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
237;4000151703;Core Evidence;journal;15551741, 1555175X;0.813;Q2;19;2;28;110;80;25;2.69;55.00;United States;Core Medical Pub;2005-ongoing;"Reviews and References (medical) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
238;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.813;Q2;72;249;801;10892;2361;793;2.97;43.74;Netherlands;Elsevier BV;1996-ongoing;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
239;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.812;Q2;90;249;769;11097;2353;672;3.71;44.57;United States;Elsevier Inc.;1981-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
240;10900153302;Biomarker Insights;journal;11772719;0.81;Q2;24;19;110;824;225;108;2.04;43.37;New Zealand;Libertas Academica;2008-ongoing;"Biochemistry (medical) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
241;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;0.81;Q1;133;1007;3373;31823;8835;3332;2.56;31.60;United Kingdom;Elsevier Ltd.;1991-ongoing;"Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Biology (Q3); Molecular Medicine (Q3)"
242;19700201201;EPMA Journal;journal;18785077, 18785085;0.807;Q2;26;38;72;2928;282;69;4.15;77.05;United Kingdom;BioMed Central;2010-ongoing;"Biochemistry (medical) (Q2); Drug Discovery (Q2); Health Policy (Q2)"
243;25214;Toxicologic Pathology;journal;15331601, 01926233;0.807;Q2;96;110;336;4219;682;324;2.02;38.35;United States;SAGE Publications;1972-ongoing;"Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q3)"
244;14487;Journal of Ocular Pharmacology and Therapeutics;journal;10807683;0.8;Q2;53;106;326;3907;605;295;2.05;36.86;United States;Mary Ann Liebert Inc.;1995-ongoing;"Ophthalmology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
245;26512;Tetrahedron;journal;00404020;0.8;Q2;209;860;3260;42614;7919;3210;2.41;49.55;United Kingdom;Elsevier Ltd.;1957-ongoing;"Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2)"
246;9000153111;Comparative Biochemistry and Physiology, Part C;journal;15320456;0.798;Q2;99;118;272;7512;750;266;2.55;63.66;Netherlands;Elsevier BV;2000-ongoing;"Biochemistry (Q2); Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2); Cell Biology (Q3); Physiology (Q3)"
247;25075;Ecotoxicology;journal;09639292, 15733017;0.797;Q2;81;129;588;7186;1348;580;2.14;55.71;Netherlands;Kluwer Academic Publishers;1992-ongoing;"Health, Toxicology and Mutagenesis (Q2); Management, Monitoring, Policy and Law (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2)"
248;19700188217;Bioanalysis;journal;17576180, 17576199;0.793;Q1;51;199;837;5841;1641;715;2.22;29.35;United Kingdom;Future Medicine Ltd.;2009-ongoing;"Medical Laboratory Technology (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Medicine (miscellaneous) (Q2)"
249;21100218055;BMC pharmacology & toxicology;journal;20506511;0.785;Q2;23;84;184;3012;429;180;1.97;35.86;United Kingdom;BioMed Central;2012-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
250;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0.784;Q2;54;52;148;1859;270;144;2.01;35.75;United States;Kluwer Academic/Plenum Publishers;1996-1999, 2001-ongoing;Pharmacology (Q2)
251;21100219314;Applied and Translational Genomics;journal;22120661;0.777;Q1;13;0;106;0;192;81;2.51;0.00;Netherlands;Elsevier BV;2012-ongoing;"Pharmaceutical Science (Q1); Biotechnology (Q2); Molecular Biology (Q3)"
252;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;0.773;Q2;98;114;367;5962;929;364;2.59;52.30;Germany;Springer Verlag;1973-ongoing;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pollution (Q2); Toxicology (Q2)"
253;130063;Pharmacological Reports;journal;17341140, 22995684;0.773;Q2;71;199;552;8885;1485;536;2.96;44.65;Netherlands;Elsevier BV;1998-2002, 2005-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
254;15840;Journal of Antibiotics;journal;00218820;0.762;Q2;73;191;440;6221;979;397;2.13;32.57;United Kingdom;Nature Publishing Group;1953-ongoing;"Drug Discovery (Q2); Pharmacology (Q2)"
255;5800173385;Recent Patents on Anti-Cancer Drug Discovery;journal;15748928;0.76;Q2;36;27;83;3115;213;78;2.64;115.37;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Cancer Research (Q3); Oncology (Q3)"
256;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0.759;Q2;95;164;447;7204;929;426;2.15;43.93;United Kingdom;Blackwell Publishing Inc.;1974-ongoing;"Pharmacology (Q2); Physiology (Q3); Physiology (medical) (Q3)"
257;19374;AAPS PharmSciTech;journal;15221059, 15309932;0.752;Q1;79;361;440;12884;1196;428;2.39;35.69;United States;American Association of Pharmaceutical Scientists;2000-ongoing;"Agronomy and Crop Science (Q1); Pharmaceutical Science (Q1); Aquatic Science (Q2); Drug Discovery (Q2); Ecology (Q2); Ecology, Evolution, Behavior and Systematics (Q2); Medicine (miscellaneous) (Q2)"
258;11300153402;Biomarkers in Medicine;journal;17520363, 17520371;0.75;Q2;37;127;383;5520;763;338;2.24;43.46;United Kingdom;Future Medicine Ltd.;2008-ongoing;"Biochemistry (medical) (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2)"
259;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.75;Q2;64;78;242;3564;587;238;2.4;45.69;Netherlands;Elsevier BV;1992-2002, 2004-ongoing;"Pharmacology (Q2); Toxicology (Q2)"
260;19700175119;Asian Journal of Pharmaceutical Sciences;journal;18180876;0.748;Q1;27;65;289;2202;794;279;1.93;33.88;China;Shenyang Pharmaceutical University;2009-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
261;20770;Drug Delivery;journal;10717544;0.748;Q1;52;200;559;10105;1679;552;3.09;50.53;United Kingdom;Taylor & Francis;1993, 1995-ongoing;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2)"
262;4700152233;Therapeutics and Clinical Risk Management;journal;11766336;0.748;Q1;43;189;538;6822;1241;515;2.22;36.10;New Zealand;Dove Medical Press Ltd;2006-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Safety Research (Q1); Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
263;18500157900;Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment;journal;19440057, 19440049;0.74;Q2;60;216;616;7579;1493;608;2.31;35.09;United States;Taylor and Francis;2008-ongoing;"Food Science (Q1); Chemistry (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
264;10300153342;Journal of medical toxicology : official journal of the American College of Medical Toxicology;journal;15569039;0.74;Q2;41;57;230;1491;446;187;2.21;26.16;United States;Springer New York LLC;2005-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
265;19900192116;Journal of Pharmaceutical Analysis;journal;20951779;0.734;Q1;21;58;150;2007;488;150;3.28;34.60;China;Xi'an Jiaotong University;2014-ongoing;"Pharmaceutical Science (Q1); Pharmacy (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Electrochemistry (Q2); Spectroscopy (Q2)"
266;23173;Korean Journal of Physiology and Pharmacology;journal;12264512;0.727;Q2;23;79;223;2992;469;218;1.6;37.87;South Korea;Eui-Hak Publishing and Printing Co.;1997-ongoing;"Pharmacology (Q2); Physiology (Q3)"
267;19700175819;Patient Preference and Adherence;journal;1177889X;0.727;Q1;37;211;619;7627;1257;597;1.85;36.15;New Zealand;Dove Medical Press Ltd;2007-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Social Sciences (miscellaneous) (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2)"
268;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790;0.726;Q1;12;105;323;2088;269;298;1.01;19.89;United States;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2); Public Health, Environmental and Occupational Health (Q2)"
269;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.724;Q2;77;169;449;8451;914;422;2.26;50.01;Canada;NRC Research Press;1964-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3); Physiology (medical) (Q3)"
270;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.722;Q2;65;129;362;3863;711;352;1.89;29.95;United Kingdom;Blackwell Publishing Inc.;1976-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
271;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.717;Q2;78;124;320;4939;493;305;1.57;39.83;United States;Springer New York LLC;1973-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Computational Theory and Mathematics (Q2); Environmental Science (miscellaneous) (Q2); Mathematics (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3); Neuroscience (miscellaneous) (Q3)"
272;12328;Current Therapeutic Research - Clinical and Experimental;journal;0011393X;0.717;Q2;34;28;73;824;143;65;1.62;29.43;United States;Elsevier Inc.;1959-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
273;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.716;Q2;88;110;433;4425;871;425;1.8;40.23;United States;Lippincott Williams & Wilkins Ltd.;1990-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2); Cancer Research (Q3); Oncology (Q3)"
274;23155;Current Vascular Pharmacology;journal;15701611;0.715;Q2;54;69;288;5349;532;231;2.14;77.52;United Arab Emirates;Bentham Science Publishers;2003-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
275;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.711;Q2;42;48;182;1750;399;180;2.14;36.46;United States;Marcel Dekker Inc.;1978-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2); Immunology (Q3); Immunology and Allergy (Q3)"
276;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0.702;Q2;22;16;54;701;103;54;2.51;43.81;United States;John Wiley and Sons Inc.;2001-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
277;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.702;Q1;52;153;509;4409;832;470;1.61;28.82;Germany;Springer Verlag;2010-ongoing;"Pharmaceutical Science (Q1); Pharmacy (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2); Toxicology (Q2)"
278;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.7;Q2;54;97;260;3318;408;254;1.44;34.21;United Kingdom;Blackwell Publishing Inc.;1978-ongoing;"Veterinary (miscellaneous) (Q1); Pharmacology (Q2)"
279;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;0.697;Q2;68;35;105;1530;276;103;2.36;43.71;Switzerland;S. Karger AG;2004-ongoing;"Dermatology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3)"
280;22319;Toxicon;journal;00410101;0.692;Q2;116;243;773;10655;1890;751;2.45;43.85;United Kingdom;Elsevier Ltd.;1962-ongoing;Toxicology (Q2)
281;21865;Fundamental and Clinical Pharmacology;journal;07673981;0.688;Q2;64;71;205;3327;452;201;2.23;46.86;United Kingdom;Blackwell Publishing Inc.;1987-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
282;22205;Saudi Pharmaceutical Journal;journal;13190164;0.687;Q1;36;178;271;5424;889;258;3.36;30.47;Saudi Arabia;King Saud University;1996-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
283;25171;Mycotoxin Research;journal;01787888;0.684;Q2;31;34;76;1702;219;75;3.07;50.06;Germany;Springer Verlag;1993-1995, 2008-ongoing;"Biotechnology (Q2); Toxicology (Q2); Microbiology (Q3)"
284;26514;Tetrahedron Letters;journal;00404039;0.683;Q2;159;1145;4614;44011;10008;4583;2.18;38.44;United Kingdom;Elsevier Ltd.;1959-ongoing;"Drug Discovery (Q2); Organic Chemistry (Q2); Biochemistry (Q3)"
285;21100455212;Biomedical Reports;journal;20499434, 20499442;0.675;Q1;15;133;296;4470;516;296;1.71;33.61;Greece;Spandidos Publications;2014-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q3)"
286;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;0.674;Q2;82;177;478;7473;1063;443;2.22;42.22;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmacology (Q2); Cancer Research (Q3); Molecular Medicine (Q3)"
287;19700174918;Clinical and Translational Science;journal;17528062, 17528054;0.669;Q1;35;67;252;2288;397;230;2.04;34.15;United States;Wiley-Blackwell;2008-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q3)"
288;23102;Journal of Pharmacy and Pharmacology;journal;00223573;0.657;Q1;107;178;505;8064;1221;496;2.45;45.30;United States;Wiley-Blackwell;1949-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
289;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.656;Q2;87;101;384;3193;798;354;2.18;31.61;United States;Lippincott Williams & Wilkins Ltd.;1979-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
290;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427835;0.655;Q2;80;173;456;6547;1198;421;2.45;37.84;United States;Wiley-Blackwell;2004-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
291;144956;Drug Metabolism and Pharmacokinetics;journal;13474367, 18800920;0.652;Q1;58;45;210;1835;442;198;2.3;40.78;United Kingdom;Elsevier Limited;2004-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
292;25093;Environmental Toxicology;journal;15227278, 15204081;0.652;Q2;69;213;477;10514;1120;475;2.44;49.36;United States;John Wiley & Sons Inc.;1980, 1999-ongoing;"Management, Monitoring, Policy and Law (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2); Health, Toxicology and Mutagenesis (Q3)"
293;21192;Drug Development Research;journal;02724391, 10982299;0.65;Q2;54;40;182;2217;400;175;2.64;55.43;United States;John Wiley & Sons Inc.;1981-ongoing;Drug Discovery (Q2)
294;23039;Journal of Liposome Research;journal;08982104, 15322394;0.65;Q2;44;36;104;1529;254;103;2.24;42.47;United States;Marcel Dekker Inc.;1988-1990, 1992-ongoing;Pharmaceutical Science (Q2)
295;4100151708;Inflammation and Allergy - Drug Targets;journal;18715281;0.649;Q2;42;0;68;0;151;61;2.3;0.00;United Arab Emirates;Bentham Science Publishers;2006-2015;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3); Immunology and Allergy (Q3)"
296;5800228222;Journal of Pharmaceutical Innovation;journal;18725120;0.644;Q2;25;35;94;1138;184;93;1.89;32.51;United States;Springer USA;2006-ongoing;"Drug Discovery (Q2); Pharmaceutical Science (Q2)"
297;19700185200;Journal of Natural Medicines;journal;18610293;0.643;Q2;37;92;260;2911;534;256;2.07;31.64;Germany;Springer Verlag;2006-ongoing;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Pharmaceutical Science (Q2)"
298;13671;Biologicals;journal;10958320, 10451056;0.636;Q2;51;103;200;3073;413;196;2;29.83;United States;Elsevier Inc.;1990-ongoing;"Applied Microbiology and Biotechnology (Q2); Bioengineering (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Immunology and Microbiology (miscellaneous)  (Q3)"
299;16803;Antiviral Chemistry and Chemotherapy;journal;09563202;0.635;Q2;46;11;32;494;61;32;1.7;44.91;United Kingdom;SAGE Publications Inc.;2017-ongoing, 1991-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Virology (Q3)"
300;21100232413;Advanced Pharmaceutical Bulletin;journal;22517308, 22285881;0.632;Q1;23;81;263;3339;697;260;2.52;41.22;Iran;Tabriz University of Medical Sciences, Faculty of Pharmacy;2011-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
301;21100238633;BioImpacts;journal;22285652, 22285660;0.629;Q2;24;32;93;1474;236;85;2.48;46.06;Iran;Tabriz University of Medical Sciences;2011-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
302;19958;Archives of Pharmacal Research;journal;02536269;0.626;Q2;75;139;618;6781;1407;595;2.43;48.78;South Korea;Pharmaceutical Society of Korea;1978-ongoing;"Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Medicine (Q3)"
303;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.626;Q2;104;321;873;10640;1534;850;1.78;33.15;Japan;Pharmaceutical Society of Japan;1993-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q2)"
304;19700200821;Therapeutic delivery;journal;20415990, 20416008;0.621;Q2;37;99;317;6153;598;267;2.4;62.15;United Kingdom;Future Medicine Ltd.;2010-ongoing;Pharmaceutical Science (Q2)
305;11000153762;Journal of Immunotoxicology;journal;1547691X, 15476901;0.62;Q3;32;28;198;1286;359;196;1.58;45.93;United States;Taylor and Francis;2004-ongoing;"Immunology (Q3); Toxicology (Q3)"
306;3500148011;Journal of Zhejiang University: Science B;journal;16731581;0.617;Q1;45;121;338;4778;654;319;2.05;39.49;China;Zhejiang University Press;2005-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Veterinary (miscellaneous) (Q2)"
307;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.616;Q1;52;194;589;4349;811;492;1.46;22.42;United States;American Association of Colleges of Pharmacy;1947-1948, 1973-1989, 1991, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Education (Q2); Medicine (miscellaneous) (Q2)"
308;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185;0.612;Q1;25;142;474;2337;470;271;1.62;16.46;India;Medknow Publications;1996-1999, 2002-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Anesthesiology and Pain Medicine (Q2); Pharmacology (medical) (Q2)"
309;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X;0.611;Q1;79;160;454;5094;803;454;1.6;31.84;Brazil;Associacao Brasileira de Divulgacao Cientifica;1973-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biophysics (Q2); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Cell Biology (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3); Physiology (Q3)"
310;19700170617;EXCLI Journal;journal;16112156;0.607;Q2;24;112;294;5083;658;243;2.64;45.38;Germany;University of Mainz;2009-ongoing;"Animal Science and Zoology (Q2); Drug Discovery (Q2); Molecular Medicine (Q3); Pharmacology (Q3)"
311;19443;American Journal of Health-System Pharmacy;journal;10792082;0.595;Q3;87;391;1114;5385;1135;677;1.6;13.77;United States;American Society of Health-System Pharmacists;1995-ongoing;"Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
312;17700156777;Advances in Pharmacological Sciences;journal;16876342, 16876334;0.591;Q1;22;5;70;447;170;70;2.47;89.40;Egypt;Hindawi Publishing Corporation;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2); Molecular Medicine (Q3)"
313;15300154846;Journal of Occupational Medicine and Toxicology;journal;17456673;0.591;Q3;33;32;138;1134;281;137;1.99;35.44;United Kingdom;BioMed Central;2006-ongoing;"Public Health, Environmental and Occupational Health (Q2); Safety Research (Q2); Toxicology (Q3)"
314;4000150314;Chemical Biology and Drug Design;journal;17470277;0.588;-;71;217;569;9942;1323;556;2.38;45.82;United Kingdom;Blackwell;2006-ongoing;"Biochemistry (Q3); Molecular Medicine (Q3)"
315;59665;Chinese Journal of Natural Medicines;journal;18755364, 20956975;0.587;Q2;27;109;376;4104;778;371;2.15;37.65;China;China Pharmaceutical University;2004-ongoing;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
316;21744;Planta Medica;journal;14390221, 00320943;0.581;Q2;103;169;575;6373;1349;547;2.26;37.71;Germany;Georg Thieme Verlag;1961, 1965-ongoing;"Complementary and Alternative Medicine (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmaceutical Science (Q2); Molecular Medicine (Q3); Pharmacology (Q3)"
317;19700177407;Interdisciplinary Toxicology;journal;13379569, 13376853;0.58;Q3;23;25;74;1070;181;73;0.88;42.80;Slovakia;Slovak Toxicology Society SETOX;2010-ongoing;"Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
318;21100367469;Toxicology Reports;journal;22147500;0.58;Q3;21;82;403;3879;712;397;1.82;47.30;Ireland;Elsevier Scientific Publishers Ireland;2014-ongoing;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
319;15581;Current Pharmaceutical Biotechnology;journal;13892010;0.574;Q2;73;134;417;7258;774;370;2.06;54.16;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Biotechnology (Q2); Pharmaceutical Science (Q2)"
320;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.574;Q2;69;36;141;785;290;139;1.99;21.81;Canada;Canadian Society for Pharmaceutical Sciences;1998-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
321;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863;0.573;Q2;69;16;44;2856;111;44;2.69;178.50;United States;Begell House;1984-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
322;4000152107;Journal of Venomous Animals and Toxins Including Tropical Diseases;journal;16789199;0.573;Q3;22;41;147;1913;287;139;1.81;46.66;United Kingdom;BioMed Central;2006-ongoing;"Animal Science and Zoology (Q2); Infectious Diseases (Q3); Parasitology (Q3); Toxicology (Q3)"
323;19900192900;Molecular Informatics;journal;18681751, 18681743;0.573;Q2;60;72;213;3162;409;201;2.07;43.92;Germany;Wiley - VCH Verlag GmbH & CO. KGaA;2010-ongoing;"Computer Science Applications (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Medicine (Q3); Structural Biology (Q4)"
324;6400153120;Chinese Medicine;journal;17498546;0.57;Q3;34;34;113;1463;220;112;1.86;43.03;United Kingdom;BioMed Central;2006-ongoing;"Complementary and Alternative Medicine (Q1); Pharmacology (Q3)"
325;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785;0.567;Q3;55;47;177;1551;297;166;1.77;33.00;United States;Mary Ann Liebert Inc.;1996-ongoing;"Medicine (miscellaneous) (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3); Oncology (Q3); Pharmacology (Q3)"
326;24797;Mini-Reviews in Medicinal Chemistry;journal;13895575;0.567;Q2;79;118;410;11918;849;377;2.2;101.00;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
327;16319;IEEE Transactions on Nanobioscience;journal;15361241;0.566;Q2;55;96;286;3733;728;272;2.39;38.89;United States;Institute of Electrical and Electronics Engineers;2002-ongoing;"Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Computer Science Applications (Q2); Electrical and Electronic Engineering (Q2); Medicine (miscellaneous) (Q2); Nanoscience and Nanotechnology (Q2); Pharmaceutical Science (Q2)"
328;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.565;Q3;53;139;213;5303;421;210;1.77;38.15;United States;John Wiley & Sons Inc.;1998-ongoing;"Medicine (miscellaneous) (Q2); Biochemistry (Q3); Health, Toxicology and Mutagenesis (Q3); Molecular Medicine (Q3); Toxicology (Q3); Molecular Biology (Q4)"
329;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.563;Q2;53;290;860;11972;1710;858;1.98;41.28;United Kingdom;Taylor & Francis;1961-1972, 1975-ongoing;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Molecular Medicine (Q3); Pharmacology (Q3)"
330;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0.562;Q3;35;80;248;3912;505;247;2.05;48.90;United Kingdom;Taylor & Francis;1991-ongoing;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
331;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.56;Q3;44;83;277;2604;486;216;2.14;31.37;Japan;Japanese Society of Toxicological Sciences;1976-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
332;25106;Human and Experimental Toxicology;journal;09603271;0.559;Q3;71;132;403;5401;727;390;1.87;40.92;United States;SAGE Publications;1981-ongoing;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
333;19600157763;Research in Pharmaceutical Sciences;journal;17355362, 17359414;0.557;Q1;20;62;172;2082;413;172;1.69;33.58;India;Medknow Publications;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
334;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.551;Q2;54;51;151;1963;307;147;1.74;38.49;United States;John Wiley & Sons Inc.;1979-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
335;13248;Experimental and Toxicologic Pathology;journal;09402993;0.551;Q3;58;83;182;3462;350;179;2.05;41.71;Netherlands;Elsevier BV;1992-ongoing;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Toxicology (Q3); Cell Biology (Q4)"
336;5800173383;Current Clinical Pharmacology;journal;15748847;0.55;Q1;33;38;113;1897;195;102;1.83;49.92;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
337;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.548;Q2;53;82;249;2585;485;243;1.99;31.52;United Kingdom;Blackwell Publishing Inc.;1979-ongoing;"Chemistry (miscellaneous) (Q2); Dermatology (Q2); Drug Discovery (Q2); Pharmaceutical Science (Q2); Aging (Q3); Colloid and Surface Chemistry (Q3)"
338;21100325142;Journal of Pharmaceutical Policy and Practice;journal;20523211;0.545;Q1;12;35;128;1268;154;118;1.85;36.23;United Kingdom;BioMed Central;2013-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Health Policy (Q2)"
339;19700174628;Iranian Journal of Basic Medical Sciences;journal;20083874, 20083866;0.538;Q2;27;183;521;7396;930;516;1.74;40.42;Iran;University of Medical Sciences;2010-ongoing;"Drug Discovery (Q2); Biochemistry (Q3); Biophysics (Q3); Clinical Biochemistry (Q3); Immunology and Microbiology (miscellaneous)  (Q3)"
340;21100241601;Toxicology Research;journal;2045452X;0.537;Q3;24;88;363;4854;705;352;2.01;55.16;United Kingdom;Royal Society of Chemistry;2012-ongoing;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
341;145693;Canadian Pharmacists Journal;journal;17151635;0.536;Q2;18;69;175;1115;157;107;1.27;16.16;Canada;Canadian Pharmacists Association;2005-ongoing;"Pharmacy (Q1); Pharmaceutical Science (Q2)"
342;16948;Chirality;journal;1520636X, 08990042;0.536;Q2;73;90;368;3432;660;354;1.87;38.13;United States;John Wiley & Sons Inc.;1989-ongoing;"Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Spectroscopy (Q2); Catalysis (Q3); Pharmacology (Q3)"
343;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.533;Q3;63;258;814;7845;1296;792;1.58;30.41;Germany;Springer Verlag;1966-ongoing;"Medicine (miscellaneous) (Q2); Pollution (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
344;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.531;Q2;32;29;92;1075;153;82;1.57;37.07;Germany;Walter de Gruyter GmbH;2015-ongoing;"Pharmacology (medical) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
345;19700174889;Drug Target Insights;journal;11773928;0.529;Q2;10;3;20;117;46;19;2.33;39.00;New Zealand;Libertas Academica;2008-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Clinical Biochemistry (Q3); Pharmacology (medical) (Q3)"
346;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115;0.528;Q2;33;25;164;1134;390;151;2.65;45.36;United Kingdom;BioMed Central;2000-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
347;19700188399;Current Protocols in Toxicology;journal;19349254, 19349262;0.527;Q3;18;24;43;548;81;43;1.48;22.83;United Kingdom;John Wiley & Sons Ltd.;2001-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
348;20570;Chemotherapy;journal;00093157, 14219794;0.524;Q2;49;44;159;943;256;154;1.71;21.43;Switzerland;S. Karger AG;1963-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
349;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.52;Q2;70;70;267;3140;507;265;1.83;44.86;United Kingdom;Taylor & Francis;1984-ongoing;"Bioengineering (Q2); Pharmaceutical Science (Q2); Colloid and Surface Chemistry (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
350;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.519;Q2;78;207;661;9376;1310;655;1.94;45.29;United States;Marcel Dekker Inc.;1974, 1976-ongoing;"Drug Discovery (Q2); Organic Chemistry (Q3); Pharmacology (Q3)"
351;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.519;Q3;43;28;90;1844;152;90;1.32;65.86;United States;Begell House;1984-1990, 1992-ongoing;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
352;19200156706;Pharmacognosy Magazine;journal;09731296, 09764062;0.519;Q2;29;262;365;8552;677;365;1.96;32.64;India;Medknow Publications;2008-ongoing;"Drug Discovery (Q2); Pharmaceutical Science (Q2)"
353;22204;Journal of Drug Delivery Science and Technology;journal;17732247;0.517;Q2;38;204;366;9810;732;360;2.46;48.09;France;Editions de Sante;2004-ongoing;Pharmaceutical Science (Q2)
354;24578;Mathematical Medicine and Biology;journal;14778599;0.517;Q3;40;24;63;613;97;62;1.56;25.54;United Kingdom;Oxford University Press;1984-1995, 2003-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Environmental Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Modeling and Simulation (Q2); Applied Mathematics (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Neuroscience (miscellaneous) (Q3); Pharmacology (Q3)"
355;17500155003;Records of Natural Products;journal;13076167;0.517;Q2;24;84;239;2548;359;238;1.5;30.33;Turkey;ACG Publications;2009-ongoing;"Drug Discovery (Q2); Plant Science (Q2); Organic Chemistry (Q3); Pharmacology (Q3)"
356;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0.515;Q3;54;0;85;0;148;83;1.43;0.00;United States;John Wiley & Sons Inc.;2003-ongoing;"Embryology (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3); Developmental Biology (Q4)"
357;19500157062;Current Cardiovascular Risk Reports;journal;19329563, 19329520;0.515;Q3;23;37;157;2124;154;156;1.01;57.41;United States;Current Medicine Group;2007-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
358;19700175023;Journal of Toxicology;journal;16878205, 16878191;0.515;Q3;26;15;72;663;164;72;2.03;44.20;Egypt;Hindawi Publishing Corporation;2010-ongoing;"Pharmacology (Q3); Toxicology (Q3)"
359;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0.513;Q3;37;28;74;1457;91;64;1.24;52.04;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Medicine (miscellaneous) (Q2); Hematology (Q3); Molecular Medicine (Q3); Pharmacology (Q3)"
360;20634;Journal of Texture Studies;journal;00224901;0.511;Q2;48;69;146;2404;244;142;1.68;34.84;United States;Wiley-Blackwell;1969-ongoing;"Food Science (Q2); Pharmaceutical Science (Q2)"
361;20602;Clinical Neuropharmacology;journal;03625664;0.506;Q3;74;65;182;1558;262;167;1.45;23.97;United States;Lippincott Williams & Wilkins Ltd.;1982-ongoing;"Neurology (clinical) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
362;19700174941;Pharmacognosy Research;journal;09748490, 09764836;0.506;Q3;25;84;195;3096;361;193;1.77;36.86;India;Medknow Publications;2010-ongoing;"Drug Discovery (Q3); Pharmacology (Q3)"
363;17700156313;Iranian Journal of Pharmaceutical Research;journal;17350328, 17266890;0.502;Q2;31;187;510;6814;823;496;1.48;36.44;Iran;Shaheed Behesti University of Medical Sciences and Health;2008-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
364;21194;Pharmacology;journal;00317012, 14230313;0.502;Q3;54;85;256;3059;395;254;1.45;35.99;Switzerland;S. Karger AG;1968-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
365;5800173387;Reviews on Recent Clinical Trials;journal;15748871;0.498;Q3;30;44;132;1905;190;117;1.01;43.30;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
366;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.495;Q2;35;226;368;8648;933;366;2.7;38.27;United States;Informa Healthcare;2013-ongoing;"Biomedical Engineering (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
367;29053;Molecular Diversity;journal;1573501X, 13811991;0.494;Q3;54;87;215;3448;485;213;2.32;39.63;Netherlands;Kluwer Academic Publishers;1995-1998, 2000, 2003-ongoing;"Information Systems (Q2); Medicine (miscellaneous) (Q2); Catalysis (Q3); Drug Discovery (Q3); Inorganic Chemistry (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3); Molecular Biology (Q4)"
368;18922;Journal of Gene Medicine;journal;1099498X, 15212254;0.493;Q3;87;52;77;2176;134;77;1.39;41.85;United States;John Wiley & Sons Inc.;1998-ongoing;"Drug Discovery (Q3); Molecular Medicine (Q3); Genetics (Q4); Genetics (clinical) (Q4); Molecular Biology (Q4)"
369;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.492;Q3;58;56;138;1662;147;119;1.2;29.68;United States;Heldref Publications;2005-ongoing;"Environmental Science (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
370;23942;Biomedical Chromatography;journal;10990801, 02693879;0.49;Q3;58;239;754;7403;1277;737;1.76;30.97;United States;John Wiley & Sons Inc.;1986-ongoing;"Analytical Chemistry (Q2); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Clinical Biochemistry (Q3); Drug Discovery (Q3); Pharmacology (Q3); Molecular Biology (Q4)"
371;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.49;Q3;42;62;170;2990;334;168;2.19;48.23;United Kingdom;Taylor & Francis;1993-ongoing;"Medicine (miscellaneous) (Q2); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
372;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0.486;Q2;14;0;30;0;51;28;1.83;0.00;United States;Marcel Dekker Inc.;1983-1990, 1992-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
373;29947;Journal of Chemotherapy;journal;1120009X;0.483;Q3;45;74;235;2082;289;214;1.33;28.14;United Kingdom;Maney Publishing;1989-ongoing;"Medicine (miscellaneous) (Q2); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
374;29634;Journal of Negative Results in BioMedicine;journal;14775751;0.483;Q2;19;15;61;483;57;59;1.02;32.20;United Kingdom;BioMed Central;2002-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
375;21100788810;Chemotherapy Research and Practice;journal;20902115, 20902107;0.481;Q2;5;0;4;0;10;4;2;0.00;United States;Hindawi Limited;2011, 2014-2015;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Oncology (Q3); Pharmacology (medical) (Q3)"
376;19700175086;Drug, Healthcare and Patient Safety;journal;11791365;0.481;Q3;18;11;55;470;100;55;1.07;42.73;New Zealand;Dove Medical Press Ltd.;2009-ongoing;"Health Policy (Q2); Pharmacology (Q3)"
377;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.479;Q2;50;115;354;4324;586;352;1.62;37.60;United States;Marcel Dekker Inc.;1996-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
378;21100220486;Journal of Pharmaceutical Investigation;journal;20935552, 20936214;0.478;Q2;16;50;174;2906;300;173;2.2;58.12;Netherlands;Springer Netherlands;2012-ongoing;"Pharmaceutical Science (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
379;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.477;Q3;41;76;283;2286;396;276;1.27;30.08;United States;John Wiley & Sons Inc.;1976-ongoing;"Analytical Chemistry (Q2); Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Spectroscopy (Q3)"
380;21100209502;Journal of Pharmacology and Pharmacotherapeutics;journal;0976500X, 09765018;0.476;Q3;26;41;189;836;242;127;1.46;20.39;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
381;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.471;Q3;45;54;272;1494;525;238;2.3;27.67;Italy;SAGE Publications Inc.;1989-ongoing;"Immunology and Allergy (Q3); Pharmacology (Q3); Immunology (Q4)"
382;14822;Xenobiotica;journal;00498254, 13665928;0.47;Q3;75;128;367;4508;594;363;1.7;35.22;United Kingdom;Taylor & Francis;1971-ongoing;"Medicine (miscellaneous) (Q2); Biochemistry (Q3); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
383;21100212330;Drug discoveries & therapeutics;journal;1881784X, 18817831;0.468;Q2;19;29;133;0;226;130;1.71;0.00;Japan;International Advancement Center for Medicine & Health Research Co., Ltd. (IACMHR Co., Ltd.);2012-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
384;18200156711;Bangladesh Journal of Pharmacology;journal;1991007X, 19910088;0.466;Q3;19;72;406;1876;360;384;0.89;26.06;Bangladesh;Bangladesh Pharmacological Society;2009-ongoing;Pharmacology (Q3)
385;21100853563;Chinese Herbal Medicines;journal;16746384;0.466;Q3;0;0;0;0;0;0;0;0.00;Netherlands;Elsevier BV;2015;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
386;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.46;Q3;38;68;195;2827;288;195;1.36;41.57;United States;Marcel Dekker Inc.;1977-ongoing;"Medicine (miscellaneous) (Q2); Chemical Health and Safety (Q3); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
387;23489;Chemical Speciation and Bioavailability;journal;09542299;0.457;Q3;25;23;86;939;136;84;1.24;40.83;United Kingdom;Taylor & Francis;1989-ongoing;"Chemical Health and Safety (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
388;130031;Journal of Toxicologic Pathology;journal;09149198;0.453;Q3;20;42;156;1103;155;109;1.34;26.26;Japan;Nihon Dokusei Byori Gakkai;1998-2002, 2004-ongoing;"Pathology and Forensic Medicine (Q3); Toxicology (Q3)"
389;18200156702;World Mycotoxin Journal;journal;18750710, 18750796;0.453;Q3;30;38;181;1690;325;176;1.86;44.47;Netherlands;Wageningen Academic Publishers;2009-ongoing;"Food Science (Q2); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
390;4700152701;Pharmacy Practice;journal;1885642X, 18863655;0.451;Q2;19;51;113;1553;153;109;1.34;30.45;Spain;Centro de Investigaciones y Publicaciones Farmaceuticas;2006-ongoing;"Pharmaceutical Science (Q2); Pharmacy (Q2)"
391;130047;Current Drug Discovery Technologies;journal;15701638;0.449;Q3;38;23;75;1136;110;73;1.58;49.39;United Arab Emirates;Bentham Science Publishers;2004-ongoing;Drug Discovery (Q3)
392;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.449;Q3;51;73;198;3105;293;190;1.68;42.53;United States;SAGE Publications;1982-ongoing;Toxicology (Q3)
393;130025;Current Drug Delivery;journal;15672018;0.443;Q2;54;108;328;6018;572;310;1.69;55.72;United Arab Emirates;Bentham Science Publishers;2004-ongoing;Pharmaceutical Science (Q2)
394;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.438;Q3;62;131;405;2905;488;395;1.2;22.18;Germany;Dustri-Verlag Dr. Karl Feistle;1994-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
395;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.434;Q2;50;108;319;3889;329;316;0.88;36.01;India;Medknow Publications;1978-ongoing;Pharmaceutical Science (Q2)
396;5400152628;Brazilian Journal of Pharmacognosy;journal;0102695X, 1981528X;0.433;Q2;37;115;305;4650;591;295;1.8;40.43;Brazil;Sociedade Brasileira de Farmacognosia;2007-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
397;130072;International Journal of Medicinal Mushrooms;journal;15219437;0.433;Q3;25;103;283;3760;394;281;1.32;36.50;United States;Begell House;2005-ongoing;"Applied Microbiology and Biotechnology (Q3); Drug Discovery (Q3); Pharmacology (Q3)"
398;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.431;Q3;62;103;299;4204;441;298;1.51;40.82;United States;Wiley-Blackwell;1986-ongoing;"Process Chemistry and Technology (Q2); Applied Microbiology and Biotechnology (Q3); Bioengineering (Q3); Biomedical Engineering (Q3); Biotechnology (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Molecular Medicine (Q4)"
399;21100262305;Clinical Pharmacology in Drug Development;journal;21607648, 2160763X;0.43;Q2;16;70;195;2064;249;180;1.5;29.49;United States;Wiley-Blackwell;2012-ongoing;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q3)"
400;19383;Fluoride - Quarterly Reports;journal;00154725;0.429;Q3;41;38;114;1179;146;102;1.22;31.03;New Zealand;International Society for Flouride Research;1973-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q2); Chemistry (miscellaneous) (Q2); Dentistry (miscellaneous) (Q2); Biochemistry (Q3); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
401;16067;Reading Teacher;journal;00340561;0.429;Q3;44;99;269;2235;182;229;0.71;22.58;United States;Wiley-Blackwell;1995-ongoing;"Language and Linguistics (Q1); Linguistics and Language (Q1); Pharmacology (Q3); Pharmacology (medical) (Q3)"
402;23348;Journal of Environmental Biology;journal;23940379, 02548704;0.424;Q3;40;184;573;5960;504;571;0.79;32.39;India;Academy of Environmental Biology;1988-ongoing;"Environmental Engineering (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
403;130089;Toxin Reviews;journal;15569543, 15569551;0.424;Q3;38;52;98;2295;150;89;1.81;44.13;United Kingdom;Taylor & Francis;1982-ongoing;Toxicology (Q3)
404;18384;Medicinal Chemistry Research;journal;10542523;0.422;Q2;38;308;1106;11295;1843;1092;1.67;36.67;United States;Birkhauser Boston;1994, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q3)"
405;19700188356;Journal of Excipients and Food Chemicals;journal;21502668;0.419;Q2;13;11;42;299;38;27;0.22;27.18;United States;IPEC-Americas;2010-ongoing;"Food Science (Q2); Pharmaceutical Science (Q2)"
406;21100239265;PharmaNutrition;journal;22134344;0.418;Q3;14;18;64;1139;105;60;1.83;63.28;Netherlands;Elsevier BV;2013-ongoing;"Food Science (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
407;5900153312;Recent Patents on Cardiovascular Drug Discovery;journal;15748901;0.415;Q3;25;0;21;0;33;19;1.29;0.00;United Arab Emirates;Bentham Science Publishers;2006-2015;"Cardiology and Cardiovascular Medicine (Q3); Drug Discovery (Q3); Pharmacology (medical) (Q3)"
408;20580;Journal of Food Biochemistry;journal;01458884;0.414;Q3;40;151;226;6730;340;224;1.47;44.57;United States;Wiley-Blackwell;1977-ongoing;"Food Science (Q2); Biophysics (Q3); Pharmacology (Q3); Cell Biology (Q4)"
409;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.413;Q2;54;83;271;3453;597;268;2.34;41.60;United Kingdom;John Wiley & Sons Ltd.;1959-1965, 1972-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
410;20545;PDA Journal of Pharmaceutical Science and Technology;journal;10797440;0.413;Q2;33;50;186;914;123;165;0.67;18.28;United States;Parenteral Drug Association Inc;1994-ongoing;Pharmaceutical Science (Q2)
411;21100444313;Sustainable Chemistry and Pharmacy;journal;23525541;0.413;Q2;9;35;27;1828;65;23;2.83;52.23;Netherlands;Elsevier BV;2015-ongoing;"Pharmaceutical Science (Q2); Environmental Chemistry (Q3); Management, Monitoring, Policy and Law (Q3); Pollution (Q3)"
412;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.412;Q3;52;82;489;1593;496;421;1.02;19.43;India;Medknow Publications;1978-1980, 1982, 1984-1986, 1994-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
413;27210;In Vivo;journal;0258851X;0.409;Q3;54;181;419;5247;506;410;1.18;28.99;Greece;International Institute of Anticancer Research;1987-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
414;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.403;Q2;35;155;469;2989;576;455;1.13;19.28;United Kingdom;Taylor & Francis;1998-ongoing;"Complementary and Alternative Medicine (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
415;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.4;Q3;58;198;365;3894;369;316;1;19.67;United States;Elsevier Inc.;2003-ongoing;"Pharmacology (nursing) (Q1); Pharmacy (Q2); Pharmacology (Q3)"
416;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.399;Q3;55;157;621;2862;558;537;1.07;18.23;United States;Lippincott Williams & Wilkins Ltd.;1960-1961, 1996-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
417;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.392;Q3;25;77;214;1972;237;209;0.9;25.61;United Kingdom;Taylor & Francis;1982-2000, 2005-ongoing;"Medicine (miscellaneous) (Q3); Toxicology (Q3)"
418;22456;International Journal of Pharmacy Practice;journal;09617671;0.391;Q2;32;65;201;1758;213;169;1.23;27.05;United Kingdom;Wiley-Blackwell;1991-ongoing;"Pharmaceutical Science (Q2); Pharmacy (Q2); Health Policy (Q3); Medicine (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q3)"
419;19700175244;Current Radiopharmaceuticals;journal;18744710;0.389;Q3;21;26;76;636;84;68;1.35;24.46;United Arab Emirates;Bentham Science Publishers;2009-ongoing;"Pharmacology (Q3); Radiology, Nuclear Medicine and Imaging (Q3)"
420;4700152769;Pharmacopeial Forum;journal;03634655;0.388;Q3;16;16;31;177;15;31;0.68;11.06;United States;Pharmacopeia;1996-1998, 2000-2017 (cancelled);"Drug Guides (Q2); Pharmacy (Q2); Pharmacology (Q3)"
421;21100446418;Contemporary Clinical Trials Communications;journal;24518654;0.387;Q3;6;116;79;4143;52;76;0.68;35.72;United States;Elsevier Inc.;2015-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
422;5800173402;Recent Patents on CNS Drug Discovery;journal;15748898;0.383;Q3;29;0;46;0;56;39;1.04;0.00;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q3)"
423;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;book series;18715125;0.381;Q2;15;8;24;703;48;0;0;87.88;United States;Elsevier Inc.;2001-2003, 2005, 2007-ongoing;"Pharmaceutical Science (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
424;3200147837;Journal of Exercise Science and Fitness;journal;1728869X;0.378;Q2;17;16;45;550;45;45;0.77;34.38;Singapore;Elsevier (Singapore) Pte Ltd;2005-ongoing;"Pharmaceutical Science (Q2); Pharmacology (nursing) (Q2); Sports Science (Q3)"
425;5800173403;Recent Patents on Anti-Infective Drug Discovery;journal;1574891X;0.376;Q3;27;14;68;610;68;54;1.47;43.57;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q3); Infectious Diseases (Q3); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
426;21717;Die Pharmazie;journal;00317144;0.375;Q2;56;127;423;4270;507;422;1.1;33.62;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1947-ongoing;Pharmaceutical Science (Q2)
427;13718;Pharmaceutical Engineering;journal;02738139;0.375;Q2;13;82;241;329;45;187;0.18;4.01;United States;International Society for Pharmaceutical Engineering, Inc.;1996-ongoing;Pharmaceutical Science (Q2)
428;11500153306;Recent Patents on Drug Delivery and Formulation;journal;18722113;0.373;Q2;25;23;71;1273;94;68;1.1;55.35;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Medicine (miscellaneous) (Q3)"
429;4700152603;Medicinal Chemistry;journal;15734064;0.372;Q3;39;83;269;4278;400;260;1.73;51.54;United Arab Emirates;Bentham Science Publishers;2005-ongoing;Drug Discovery (Q3)
430;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.371;Q3;52;94;483;3643;638;468;1.37;38.76;United States;SAGE Publications;1985-ongoing;"Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
431;19700180522;Molecular and Cellular Toxicology;journal;1738642X;0.369;Q2;18;50;153;2270;229;150;1.67;45.40;Germany;Springer Verlag;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pathology and Forensic Medicine (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
432;11400153330;Recent Patents on Endocrine, Metabolic and Immune Drug Discovery;journal;18722148;0.369;Q3;20;8;58;478;79;54;1.23;59.75;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Biochemistry (medical) (Q3); Drug Discovery (Q3); Endocrinology, Diabetes and Metabolism (Q3); Immunology and Allergy (Q3); Medicine (miscellaneous) (Q3)"
433;21100218529;Value in Health Regional Issues;journal;22121099, 22121102;0.366;Q2;12;54;174;1481;133;157;0.77;27.43;United States;Elsevier USA;2012-ongoing;"Economics, Econometrics and Finance (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Health Policy (Q3)"
434;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.364;Q3;84;172;585;5822;779;580;1.33;33.85;Japan;Pharmaceutical Society of Japan;1958, 1962-ongoing;"Chemistry (miscellaneous) (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
435;19398;Acta Pharmaceutica;journal;13300075;0.362;Q2;49;40;124;1054;189;124;1.26;26.35;Croatia;Hrvatsko Farmaceutsko Drustvo/Croatian Pharmaceutical Society;1992-ongoing;"Pharmaceutical Science (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
436;79053;Natural Product Sciences;journal;12263907;0.361;Q3;22;50;153;1253;141;150;0.94;25.06;South Korea;Korean Society of Pharmacognosy;1997-ongoing;"Drug Discovery (Q3); Organic Chemistry (Q3)"
437;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;0.359;Q3;79;48;489;2976;573;486;1.16;62.00;United States;Wiley-Blackwell;1918-ongoing;"Drug Discovery (Q3); Inorganic Chemistry (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3); Biochemistry (Q4); Catalysis (Q4)"
438;4000148204;Pakistan Journal of Pharmaceutical Sciences;journal;1011601X;0.358;Q2;35;222;982;6767;922;982;0.86;30.48;Pakistan;University of Karachi;2005-ongoing;Pharmaceutical Science (Q2)
439;21100318814;Pharmaceutical patent analyst;journal;20468962;0.358;Q2;13;30;130;0;104;102;0.9;0.00;United Kingdom;Future Science;2012-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
440;21256;Drugs of Today;journal;16993993, 16994019;0.357;Q3;46;53;192;1518;223;186;1.48;28.64;Spain;Prous Science;1968, 1978-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
441;21100366771;Journal of Applied Research on Medicinal and Aromatic Plants;journal;22147861;0.355;Q3;11;60;80;2284;149;79;2.08;38.07;Germany;Elsevier GmbH;2014-ongoing;"Drug Discovery (Q3); Plant Science (Q3)"
442;25864;Heterocycles;journal;03855414;0.354;Q3;61;199;718;7695;699;713;1;38.67;Netherlands;Elsevier BV;1983, 1985-ongoing;"Analytical Chemistry (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
443;21100241608;Journal of Nanomedicine and Nanotechnology;journal;21577439;0.351;Q2;19;0;18;0;33;18;0;0.00;India;OMICS Publishing Group;2010-2014 (cancelled);"Pharmaceutical Science (Q2); Bioengineering (Q3); Biomedical Engineering (Q3); Medicine (miscellaneous) (Q3)"
444;17700155034;Natural product communications;journal;15559475, 1934578X;0.351;Q3;35;464;1451;12726;1282;1410;0.85;27.43;United States;Natural Product Communications;2008-ongoing;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Plant Science (Q3)"
445;21100804457;Current Opinion in Toxicology;journal;24682020;0.349;Q4;7;67;18;3496;25;18;1.39;52.18;Netherlands;Elsevier BV;2016-ongoing;Toxicology (Q4)
446;5800173386;Current Drug Safety;journal;15748863;0.348;Q3;31;35;133;959;143;123;1.22;27.40;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3); Toxicology (Q4)"
447;130045;Journal of Applied Biomedicine;journal;12140287, 1214021X;0.348;Q2;26;39;105;1897;197;103;1.9;48.64;Spain;Elsevier Espana;2005-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q3)"
448;4500151530;Personalized Medicine;journal;17410541;0.348;Q3;24;65;210;2528;194;180;0.93;38.89;United Kingdom;Future Medicine Ltd.;2006-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
449;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073;0.346;Q3;59;95;291;3663;286;256;1.16;38.56;United Arab Emirates;Bentham Science Publishers;1998-ongoing;"Computer Science Applications (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Organic Chemistry (Q3)"
450;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.342;Q3;30;73;207;3063;273;205;1.44;41.96;Germany;Walter de Gruyter GmbH;1985-1988, 1990-ongoing;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Physiology (Q4)"
451;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.341;Q4;26;39;128;1734;164;117;1.24;44.46;Croatia;Institute for Medical Research and Occupational Health;1953-ongoing;"Public Health, Environmental and Occupational Health (Q3); Toxicology (Q4)"
452;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;03787966;0.338;Q3;34;97;185;3541;227;179;1.33;36.51;France;Springer Paris;1976-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
453;19700201141;Journal of Ayurveda and Integrative Medicine;journal;09759476, 09762809;0.338;Q3;19;51;143;1362;126;113;1.14;26.71;Netherlands;Elsevier BV;2010-ongoing;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3)"
454;19700201144;Journal of Pharmacy and Bioallied Sciences;journal;09764879, 09757406;0.338;Q2;27;106;465;2429;524;442;0.94;22.92;India;Medknow Publications and Media Pvt. Ltd;2011-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Bioengineering (Q3)"
455;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;0.336;Q3;36;8;80;502;66;68;0.89;62.75;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Cardiology and Cardiovascular Medicine (Q3); Hematology (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
456;21100470510;Drug Research;journal;21949379, 21949387;0.334;Q3;56;114;382;3605;385;366;1.05;31.62;Germany;Thieme;1972, 2013-ongoing;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
457;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.333;Q3;30;52;170;2079;193;168;1.22;39.98;Germany;Springer Verlag;1996-2002, 2005-ongoing;"Analytical Chemistry (Q3); Bioengineering (Q3); Drug Discovery (Q3); Biochemistry (Q4); Molecular Medicine (Q4)"
458;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X;0.328;Q3;18;114;372;1040;137;163;0.74;9.12;United States;Medical Letter, Inc.;1965-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
459;19700200860;International Journal of Current Pharmaceutical Review and Research;journal;0976822X;0.325;Q2;9;2;169;72;54;169;0.32;36.00;India;Publishers, In-IJCPR;2010-2016 (cancelled);Pharmaceutical Science (Q2)
460;23412;Journal of AOAC International;journal;10603271;0.324;Q3;79;241;672;5322;685;653;1.03;22.08;United States;AOAC International;1993-ongoing;"Agronomy and Crop Science (Q3); Analytical Chemistry (Q3); Food Science (Q3); Pharmacology (Q3); Environmental Chemistry (Q4)"
461;144879;Toxicology International;journal;09716580;0.324;Q4;21;32;188;711;119;181;0.26;22.22;India;Society of Toxicology;2005-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
462;4600151527;Infectious Disorders - Drug Targets;journal;18715265;0.323;Q3;49;29;88;905;79;76;1.06;31.21;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
463;18800156720;Dissolution Technologies;journal;1521298X;0.321;Q2;28;27;88;620;57;68;0.48;22.96;United States;Dissolution Technologies, Inc.;2008-ongoing;Pharmaceutical Science (Q2)
464;21100815317;Journal of Pharmacopuncture;journal;20936966, 22346856;0.321;Q3;7;34;38;1267;37;38;0.97;37.26;South Korea;Korean Pharmacopuncture Institute;2016-ongoing;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
465;21100449106;Drug Delivery Letters;journal;22103031, 2210304X;0.314;Q2;0;0;0;0;0;0;0;0.00;Netherlands;Bentham Science Publishers B.V.;2014, 2016-ongoing;"Pharmaceutical Science (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biomedical Engineering (Q3)"
466;11200153563;Drug Metabolism Letters;journal;18723128;0.314;Q2;23;19;72;820;58;65;0.84;43.16;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Pharmaceutical Science (Q2); Biochemistry (medical) (Q3); Clinical Biochemistry (Q3); Pharmacology (medical) (Q3)"
467;11400153335;Recent Patents on Inflammation and Allergy Drug Discovery;journal;1872213X;0.314;Q3;21;13;61;1038;77;57;1.4;79.85;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Immunology and Allergy (Q4)"
468;21100788832;International Journal of Medicinal Chemistry;journal;20902069, 20902077;0.31;Q3;3;0;6;0;7;6;0.75;0.00;United States;Hindawi Publishing Corporation;2014-ongoing;"Drug Discovery (Q3); Biochemistry (Q4); Molecular Medicine (Q4)"
469;19700201137;Journal of Advanced Pharmaceutical Technology and Research;journal;01105558, 09762094;0.309;Q2;26;31;108;678;129;93;1.3;21.87;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;Pharmaceutical Science (Q2)
470;19700177128;Journal of Young Pharmacists;journal;09751505, 09751483;0.306;Q2;22;139;198;3324;153;187;0.83;23.91;India;EManuscript Services;2010-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
471;21810;Farmacia;journal;00148237;0.304;Q2;19;149;399;4114;459;399;1.38;27.61;Romania;Uniunea Societatilor De Stiinte Medicale;1973-1987, 2008-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
472;19500157042;Currents in Pharmacy Teaching and Learning;journal;18771297;0.3;Q2;14;164;366;3685;257;353;0.66;22.47;Netherlands;Elsevier BV;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacy (Q2)"
473;3900148201;International Journal of Pharmacology;journal;18125700, 18117775;0.3;Q3;29;115;266;5928;242;266;0.88;51.55;Pakistan;Asian Network for Scientific Information;2006-ongoing;Pharmacology (Q3)
474;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.297;Q4;55;33;169;934;149;134;1.3;28.30;United Kingdom;Fund for the Replacement of Animals in Medical Experiments;1982, 1985-1986, 1988-1989, 1994-ongoing;"Medical Laboratory Technology (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Toxicology (Q4)"
475;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.297;Q2;46;120;573;4358;487;569;0.93;36.32;United States;Marcel Dekker Inc.;1996-ongoing;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Clinical Biochemistry (Q3); Biochemistry (Q4)"
476;19700189400;Pharmaceutical Sciences;journal;23832886, 1735403X;0.295;Q2;12;48;113;1585;150;107;1.51;33.02;Iran;Tabriz University of Medical Sciences;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
477;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.293;Q2;35;211;466;6614;385;458;0.65;31.35;Poland;Polskie Towarzystwo Farmaceutyczne/Polish Pharmaceutical Society;1951-1955, 1961-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
478;4700152612;Current Nanoscience;journal;15734137;0.292;Q2;37;76;347;3682;379;323;1.31;48.45;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmaceutical Science (Q2); Bioengineering (Q3); Biomedical Engineering (Q3); Biotechnology (Q3); Medicine (miscellaneous) (Q3); Nanoscience and Nanotechnology (Q3)"
479;21100798510;Journal of Intercultural Ethnopharmacology;journal;21468397;0.285;Q3;7;57;65;2724;69;62;1.11;47.79;Turkey;Ejmanager LLC;2016-2017 (cancelled);"Complementary and Alternative Medicine (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3); Toxicology (Q4)"
480;19700175004;Open Medicinal Chemistry Journal;journal;18741045;0.281;Q2;15;15;11;649;10;11;0.71;43.27;United Arab Emirates;Bentham Science Publishers;2009-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
481;21100285419;Expert Opinion on Orphan Drugs;journal;21678707;0.279;Q2;13;100;387;8193;253;372;0.78;81.93;United Kingdom;Taylor & Francis;2013-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Health Policy (Q3); Pharmacology (medical) (Q3)"
482;21100833039;Journal of HerbMed Pharmacology;journal;23455004;0.272;Q3;8;33;63;926;77;63;1.22;28.06;Iran;Nickan Research Institute;2015-ongoing;Drug Discovery (Q3)
483;19700180781;Strategies and Tactics in Organic Synthesis;book series;18746004;0.272;Q3;8;18;27;1350;11;0;0;75.00;United States;Elsevier Inc.;2004-2005, 2008, 2012-ongoing;"Drug Discovery (Q3); Organic Chemistry (Q4)"
484;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.268;Q2;34;37;168;1220;146;164;0.78;32.97;Austria;MDPI AG;1960-1961, 1973-ongoing;Pharmaceutical Science (Q2)
485;4700152609;Current Computer-Aided Drug Design;journal;15734099;0.259;Q3;24;34;116;1286;101;100;0.9;37.82;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Molecular Medicine (Q4)"
486;18800156708;Tropical Journal of Pharmaceutical Research;journal;15965996;0.256;Q3;29;381;962;8939;661;957;0.52;23.46;Nigeria;University of Benin;2009-ongoing;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
487;35190;Revista Espanola de Quimioterapia;journal;02143429;0.254;Q3;23;103;221;2244;128;198;0.58;21.79;Spain;Sociedad Española de Quimioterapia;1989-ongoing;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3)"
488;21758;Prescrire International;journal;11677422;0.252;Q3;11;58;536;723;100;474;0.19;12.47;France;Association Mieux Prescrire;1996-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
489;19700174961;BioProcess International;trade journal;15426319;0.248;Q3;20;39;374;234;85;371;0.25;6.00;United States;BioProcess International;2009-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Drug Discovery (Q3)"
490;130038;Letters in Drug Design and Discovery;journal;15701808;0.247;Q3;28;149;371;5398;359;368;0.88;36.23;United Arab Emirates;Bentham Science Publishers;2005-ongoing;"Drug Discovery (Q3); Pharmaceutical Science (Q3); Molecular Medicine (Q4)"
491;21100236605;Journal of Applied Pharmaceutical Science;journal;22313354;0.244;Q2;28;393;929;13286;679;922;0.69;33.81;India;MediPoeia;2011-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
492;19700175099;Topics in Medicinal Chemistry;book series;18622461;0.244;Q3;8;22;83;2886;44;74;0.45;131.18;Germany;Springer Verlag;2009-ongoing;"Drug Discovery (Q3); Molecular Medicine (Q4)"
493;4700152608;African Journal of Traditional, Complementary and Alternative Medicines;journal;01896016;0.242;Q3;36;134;460;284;319;457;0.42;2.12;Nigeria;African Networks on Ethnomedicines;1970, 1973-1978, 1981-1982, 1991, 1995, 2002, 2006-2016 (cancelled);"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
494;21100853500;Clinical Cancer Drugs;journal;22126988, 2212697X;0.242;Q2;3;0;6;0;7;6;1.17;0.00;United Arab Emirates;Bentham Science Publishers;2015-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Oncology (Q3); Cancer Research (Q4)"
495;21100199816;Jundishapur Journal of Natural Pharmaceutical Products;journal;22287876, 17357780;0.236;Q2;15;56;128;1936;124;123;0.67;34.57;Netherlands;Kowsar Publishing Company;2011-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
496;15600154705;EnvironmentAsia;journal;19061714;0.233;Q4;14;33;93;1013;58;93;0.64;30.70;Thailand;Thai Society of Higher Education Institutes on Environment;2009-ongoing;"Environmental Science (miscellaneous) (Q3); Toxicology (Q4)"
497;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.232;Q3;22;51;149;1608;104;142;0.87;31.53;France;Elsevier Masson;1946-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
498;19600161802;International Journal of Computational Biology and Drug Design;journal;17560764, 17560756;0.231;Q3;12;24;68;782;34;66;0.28;32.58;United Kingdom;Inderscience Enterprises;2008-ongoing;"Computer Science Applications (Q3); Drug Discovery (Q3)"
499;4700152426;Current Pharmaceutical Analysis;journal;15734129;0.224;Q3;22;71;144;2018;105;135;0.78;28.42;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmaceutical Science (Q3); Biochemistry (Q4); Biophysics (Q4); Molecular Medicine (Q4)"
500;19700174810;International Journal of Pharmacy and Pharmaceutical Sciences;journal;09751491;0.224;Q3;37;8;3373;414;2679;3349;0.77;51.75;India;International Journal of Pharmacy and Pharmaceutical Sciences;2009-2016 (cancelled);"Pharmaceutical Science (Q3); Pharmacology (Q3)"
501;19700174904;Asian Journal of Pharmaceutical and Clinical Research;journal;09742441, 24553891;0.223;Q3;26;1278;1503;34293;757;1499;0.48;26.83;India;Asian Journal of Pharmaceutical and Clinical Research;2009-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
502;19200156945;Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas;journal;07177917;0.222;Q3;16;41;139;2250;93;139;0.66;54.88;Chile;Universidad de Santiago de Chile;2008-ongoing;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q3); Pharmacology (Q3); Plant Science (Q3)"
503;144963;Drug Discovery Today: Disease Models;journal;17406757;0.218;Q3;23;25;82;1399;52;72;0.38;55.96;Netherlands;Elsevier BV;2004-ongoing;"Drug Discovery (Q3); Molecular Medicine (Q4)"
504;19400157518;Rasayan Journal of Chemistry;journal;09760083, 09741496;0.218;Q2;18;200;256;5177;173;256;0.79;25.89;India;Rasayan Journal;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Chemical Engineering (miscellaneous) (Q3); Chemistry (miscellaneous) (Q3); Energy (miscellaneous) (Q3); Biochemistry (Q4)"
505;21100304895;Archives of Clinical Infectious Diseases;journal;23452641;0.217;Q4;10;53;116;1328;68;105;0.67;25.06;Iran;Shahid Beheshti University of Medical Sciences;2012-ongoing;"Cardiology and Cardiovascular Medicine (Q3); Critical Care and Intensive Care Medicine (Q3); Infectious Diseases (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
506;21811;Farmacia Hospitalaria;journal;11306343;0.215;Q3;21;94;218;1455;106;166;0.66;15.48;Spain;Aran Ediciones SA;1990-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
507;37697;Autonomic and Autacoid Pharmacology;journal;14748665;0.214;Q3;30;9;17;284;17;15;1.31;31.56;United Kingdom;Blackwell Publishing Inc.;2002-ongoing;Pharmacology (Q3)
508;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.214;Q2;32;108;281;3903;205;275;0.55;36.14;Brazil;Universidade de Sao Paulo;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
509;21100223537;European Journal of Hospital Pharmacy: Science and Practice;journal;20479956, 20479964;0.213;Q2;11;97;268;1586;102;210;0.52;16.35;Belgium;European Association of Hospital Pharmacists (EAHP);2012-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
510;21100463829;Chinese Journal of Population Resources and Environment;journal;23254262, 10042857;0.212;Q4;9;46;83;1070;49;82;0.6;23.26;United Kingdom;Taylor and Francis Ltd.;2015-ongoing;"Demography (Q3); Environmental Science (miscellaneous) (Q3); Toxicology (Q4)"
511;29845;IARC Monographs on the Evaluation of Carcinogenic Risks to Humans;journal;10171606;0.211;Q4;38;6;29;2272;24;22;0.5;378.67;France;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-ongoing;"Cancer Research (Q4); Toxicology (Q4)"
512;21100201517;RSC Drug Discovery Series;book series;20413203;0.21;Q3;7;52;243;6187;89;127;0.78;118.98;United Kingdom;Royal Society of Chemistry;2010, 2014-ongoing;Drug Discovery (Q3)
513;22338;Hospital Pharmacy;journal;00185787;0.207;Q3;21;130;458;2025;188;407;0.41;15.58;United States;Thomas Land Publishers Inc.;1973-ongoing;"Pharmacy (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
514;21100256959;Biomarkers and Genomic Medicine;journal;22140247;0.206;Q3;7;0;51;0;41;51;1;0.00;United States;Elsevier BV;2013-2015;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Biomedical Engineering (Q4)"
515;19700180785;Studies in Natural Products Chemistry;book series;15725995;0.206;Q4;33;47;147;6735;138;27;5.92;143.30;Netherlands;Elsevier BV;1995-1997, 2000-2003, 2005-2006, 2008, 2012-ongoing;"Drug Discovery (Q4); Organic Chemistry (Q4)"
516;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.205;Q3;45;64;191;1709;91;171;0.41;26.70;India;All India Institute of Medical Sciences;1959-ongoing;"Pharmacology (Q3); Physiology (Q4); Physiology (medical) (Q4)"
517;145096;Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology;journal;14198711;0.205;Q2;14;22;72;994;24;63;0.33;45.18;Hungary;Neuroline;2004-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Neurology (clinical) (Q3); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4)"
518;11900154394;Oriental Journal of Chemistry;journal;0970020X, 22315039;0.205;Q4;18;396;984;10871;642;984;0.67;27.45;India;Scientific Publishers;2008-ongoing;"Chemistry (miscellaneous) (Q3); Biochemistry (Q4); Drug Discovery (Q4); Environmental Chemistry (Q4)"
519;19700174658;Regulatory Rapporteur;trade journal;17428955;0.205;Q2;5;65;202;570;17;137;0.13;8.77;United Kingdom;The Organisation for Professionals in Regulatory Affairs;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacy (Q2)"
520;21100853513;Pharmaceutical Nanotechnology;journal;22117385, 22117393;0.202;Q3;3;0;11;0;5;11;0.33;0.00;Netherlands;Bentham Science Publishers B.V.;2014-ongoing;"Pharmaceutical Science (Q3); Biomedical Engineering (Q4)"
521;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117;0.201;Q3;36;25;65;566;37;65;0.48;22.64;United States;Old City Publishing Inc.;1996, 2002-ongoing;"Pharmacology (Q3); Cancer Research (Q4); Drug Discovery (Q4)"
522;21100426011;Nano LIFE;journal;17939852, 17939844;0.201;Q3;1;0;1;0;0;1;0;0.00;Singapore;World Scientific Publishing Co. Pte Ltd;2014-2015;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Bioengineering (Q4); Biomedical Engineering (Q4)"
523;19700174978;American Journal of Pharmacy Benefits;journal;19454481;0.2;Q2;11;26;139;446;37;115;0.35;17.15;United States;Managed Care & Healthcare Communications LLC;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Business and International Management (Q3); Decision Sciences (miscellaneous) (Q4)"
524;21100440523;Interaction Design and Architecture(s);journal;18269745, 22832998;0.199;Q3;8;46;113;1703;90;104;0.78;37.02;Italy;Scuola IaD;2015-ongoing;"Architecture (Q2); Media Technology (Q2); Human-Computer Interaction (Q3); Pharmacology (Q3); Social Sciences (miscellaneous) (Q3); Computer Science Applications (Q4)"
525;16698;Revista Brasileira de Plantas Medicinais;journal;15160572;0.199;Q3;23;0;364;0;194;350;0.41;0.00;Brazil;Fundacao do Instituto de Biociencias;1999-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
526;21100853564;AAPS Advances in the Pharmaceutical Sciences Series;book series;22107371, 2210738X;0.198;Q3;6;0;87;0;25;59;0.57;0.00;Germany;Springer Verlag;2014-ongoing;Pharmaceutical Science (Q3)
527;20564;Ceska a Slovenska Farmacie;journal;12107816, 18054439;0.197;Q3;15;28;94;1205;38;91;0.49;43.04;Czech Republic;Nakladatelske Stredisko CLSJE Purkyne;1994-ongoing;Pharmaceutical Science (Q3)
528;4700152607;Current Enzyme Inhibition;journal;15734080;0.197;Q4;15;21;56;1234;33;50;0.66;58.76;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
529;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.197;Q3;26;227;510;4030;218;498;0.4;17.75;United States;Kluwer Academic/Plenum Publishers;1967-1977, 1979-1994, 1996-ongoing;"Pharmacology (Q3); Drug Discovery (Q4)"
530;110097;Food and Drug Law Journal;journal;1064590X;0.194;Q3;18;24;75;1738;36;73;0.48;72.42;United States;Food and Drug Law Institute;1992-ongoing;"Law (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q4)"
531;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0.194;Q3;15;3;43;83;13;32;0;27.67;United States;SAGE Publications Inc.;2000-ongoing;"Marketing (Q3); Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Strategy and Management (Q3)"
532;19800188074;Medicinal Plants - International Journal of Phytomedicines and Related Industries;journal;09754261, 09756892;0.193;Q4;8;48;133;1119;23;129;0.23;23.31;Netherlands;IOS Press;2010-ongoing;"Drug Discovery (Q4); Organic Chemistry (Q4); Plant Science (Q4)"
533;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.192;Q3;24;33;101;1142;57;100;0.6;34.61;United States;The Haworth Herbal Press;1992-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
534;19700175785;Open Access Journal of Clinical Trials;journal;11791519;0.192;Q3;9;8;18;278;13;18;0.82;34.75;New Zealand;Dove Medical Press Ltd;2009-ongoing;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
535;21100788744;OpenNano;journal;23529520;0.192;Q3;4;8;4;408;2;4;0.5;51.00;United States;Elsevier Inc.;2016-ongoing;"Internal Medicine (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Biotechnology (Q4)"
536;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.192;Q3;17;272;816;1470;41;780;0.06;5.40;Germany;Editio Cantor Verlag;1960-1961, 1973-ongoing;Pharmaceutical Science (Q3)
537;21100218041;Anti-Infective Agents;journal;22113533, 22113525;0.191;Q3;21;17;63;626;39;56;0.58;36.82;United Arab Emirates;Bentham Science Publishers;2012-ongoing;"Pharmacology (Q3); Infectious Diseases (Q4)"
538;19408;Actualites Pharmaceutiques;journal;05153700;0.19;Q4;5;178;499;1195;19;402;0.05;6.71;Netherlands;Elsevier BV;1961, 1963, 1996-ongoing;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
539;4600151507;Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry;journal;18715230;0.189;Q4;19;15;71;558;48;65;0.52;37.20;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q3); Immunology (Q4); Immunology and Allergy (Q4); Pharmacology (Q4)"
540;19700201423;Journal of Pharmaceutical Health Services Research;journal;17598885, 17598893;0.189;Q3;12;39;104;1108;45;92;0.55;28.41;United Kingdom;John Wiley and Sons Ltd;2010-ongoing;"Economics, Econometrics and Finance (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
541;58808;Pharmaceutical Care and Research;journal;16712838;0.188;Q3;7;137;434;1609;29;431;0.08;11.74;China;Yao xue fu wu yu yan jiu za zhi she;2004-ongoing;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
542;21100226424;Toxicology and Environmental Health Sciences;journal;20059752;0.188;Q4;12;42;113;1754;63;112;0.55;41.76;South Korea;Korean Society of Environmental Risk Assessment and Health Science;2009-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
543;19700189100;Pharmaceutical Medicine;journal;11782595, 14735679;0.187;Q4;15;34;75;1474;42;63;0.53;43.35;United Kingdom;Adis International Ltd.;2008-ongoing;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
544;17700156303;Neuromethods;book series;19406045, 08932336;0.185;Q3;17;171;655;9450;171;399;0.46;55.26;United States;Humana Press, Inc.;2009-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q4); Psychiatry and Mental Health (Q4)"
545;21100376682;Toxicologie Analytique et Clinique;journal;23520078;0.185;Q4;5;46;126;1653;40;107;0.4;35.93;Italy;Elsevier Masson SAS;2014-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
546;5800173401;Current Bioactive Compounds;journal;15734072;0.183;Q3;21;39;113;1610;71;101;0.7;41.28;United Arab Emirates;Bentham Science Publishers;2007-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
547;19700174893;Dhaka University Journal of Pharmaceutical Sciences;journal;18161839, 18161820;0.183;Q3;10;30;97;892;38;94;0.38;29.73;Bangladesh;University of Dhaka;2007-ongoing;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
548;19600162009;Advances in Molecular Toxicology;book series;18720854;0.182;Q4;10;7;24;1294;12;0;0;184.86;Netherlands;Elsevier BV;2006, 2008-ongoing;"Health, Toxicology and Mutagenesis (Q4); Pharmacology (Q4); Toxicology (Q4)"
549;21100228007;Archives of Razi Institute;journal;03653439;0.182;Q4;5;32;93;775;30;93;0.34;24.22;Iran;Razi Vaccine and Serum Research Institute;2012-ongoing;"Veterinary (miscellaneous) (Q3); Immunology and Microbiology (miscellaneous)  (Q4); Toxicology (Q4)"
550;22881;Yao xue xue bao = Acta pharmaceutica Sinica;journal;05134870;0.182;Q3;29;260;785;7946;382;785;0.52;30.56;China;Nongton Jie;1960, 1962-1966, 1979-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Molecular Medicine (Q4)"
551;21100208082;VacciMonitor;journal;10250298, 1025028X;0.177;Q4;3;13;33;236;13;31;0.14;18.15;Cuba;Instituto Finlay, Centro de Investigacion-Produccion de Vacunas y Sueros;2012-ongoing;"Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Molecular Medicine (Q4)"
552;19700175096;Pharmacognosy Journal;journal;09753575;0.176;Q4;14;133;261;4141;124;258;0.67;31.14;India;Pharmacognosy Network Worldwide;2009-ongoing;"Drug Discovery (Q4); Pharmacology (Q4)"
553;20065;BioPharm International;journal;1542166X;0.172;Q3;25;136;369;794;62;216;0.41;5.84;United States;UBM Medica Periodical Publication;2002-ongoing;"Pharmaceutical Science (Q3); Biotechnology (Q4)"
554;19700174609;Clinical Medicine Insights: Therapeutics;journal;1179559X;0.172;Q3;6;24;21;1253;9;21;0.47;52.21;New Zealand;Libertas Academica;2010-ongoing;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (Q4)"
555;19700181241;Physiology and Pharmacology;journal;24765236, 24765244;0.172;Q4;9;38;124;1831;57;123;0.51;48.18;Iran;Neuroscience Research Center;2009-ongoing;"Pharmacology (Q4); Physiology (Q4)"
556;19700188326;American Journal of Drug Discovery and Development;journal;2150427X, 21504296;0.171;Q4;9;0;25;0;18;25;0.33;0.00;United States;Academic Journals Inc.;2011-2016 (cancelled);Drug Discovery (Q4)
557;5400152620;American Journal of Pharmacology and Toxicology;journal;15574970, 15574962;0.17;Q3;16;0;34;0;20;31;0.45;0.00;United States;Science Publications;2007-2016 (cancelled);"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
558;21100201958;Journal of Chinese Pharmaceutical Sciences;journal;10031057;0.168;Q3;10;95;326;2673;97;319;0.27;28.14;China;Editorial Office of Journal of Chinese Pharmaceutical Sciences;2011-ongoing;Pharmaceutical Science (Q3)
559;21211;Pharmacy Education;journal;14772701, 15602214;0.168;Q3;15;34;98;841;28;98;0.26;24.74;United Kingdom;Taylor & Francis;1973-1978, 2002-ongoing;"Pharmaceutical Science (Q3); Pharmacy (Q3); Education (Q4)"
560;19446;American Pharmaceutical Review;journal;10998012;0.167;Q3;20;93;265;1322;48;241;0.15;14.22;United States;Russell Publishing LLC;2002-ongoing;Pharmaceutical Science (Q3)
561;4600151506;Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry;journal;18715222;0.167;Q4;14;15;62;690;17;53;0.18;46.00;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Endocrinology, Diabetes and Metabolism (Q4); Immunology and Allergy (Q4); Pharmacology (Q4)"
562;21100301603;National Journal of Physiology, Pharmacy and Pharmacology;journal;23204672;0.166;Q3;7;278;284;6167;91;278;0.34;22.18;India;Mrs Dipika Charan for MedScience Publishers;2011-2017 (cancelled);"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Physiology (Q4)"
563;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.165;Q3;26;517;2527;3822;759;2527;0.25;7.39;China;Zhongguo Zhongyi Yanjiuyuan;1989-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
564;19200156925;Cancer Therapy;journal;15439143, 15439135;0.164;Q4;8;0;4;0;5;4;0;0.00;United States;Gene Therapy Press;2009-2014;"Cancer Research (Q4); Oncology (Q4); Pharmacology (Q4)"
565;17700155411;Research Journal of Environmental Toxicology;journal;18193420;0.164;Q4;12;0;66;0;38;66;0.55;0.00;United States;Academic Journals Inc.;2009-2016 (cancelled);"Health, Toxicology and Mutagenesis (Q4); Pollution (Q4); Toxicology (Q4)"
566;19700173109;Contract Pharma;trade journal;15443469;0.163;Q3;3;102;363;150;12;355;0.04;1.47;United States;Contract Pharma;2009-ongoing;"Industrial Relations (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
567;5800179590;Pharmacologyonline;journal;18278620;0.163;Q4;21;57;216;2079;62;216;0.22;36.47;Italy;SILAE;2007-ongoing;"Drug Discovery (Q4); Pharmacology (Q4)"
568;21412;Zeitschrift für Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.163;Q4;12;50;162;658;13;113;0.1;13.16;Germany;Hippokrates Verlag;1982, 1985-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
569;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699;0.162;Q3;43;1;310;44;125;309;0.41;44.00;India;Scientific Publishers;1970, 1973-1978, 1981, 1989-1991, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Organic Chemistry (Q4)"
570;19200156909;Indian Journal of Pharmaceutical Education and Research;journal;00195464;0.162;Q3;17;193;222;4789;96;219;0.41;24.81;India;Association of Pharmaceutical Teachers of India;2008-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
571;5800173394;Current Drug Therapy;journal;15748855;0.161;Q3;14;16;63;556;30;56;0.7;34.75;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)"
572;21100195303;Eurasian Journal of Analytical Chemistry;journal;13063057;0.16;Q3;8;139;47;3959;19;47;0.47;28.48;Turkey;Moment Publications;2011-ongoing;"Pharmaceutical Science (Q3); Analytical Chemistry (Q4); Electrochemistry (Q4); Spectroscopy (Q4)"
573;19700174971;Indian Journal of Forensic Medicine and Toxicology;journal;09739122, 09739130;0.16;Q4;18;127;412;2111;26;411;0.06;16.62;India;Aall India Institute of Medical Sciences;2008-ongoing;"Law (Q3); Health, Toxicology and Mutagenesis (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
574;21100399725;Journal of Reports in Pharmaceutical Sciences;journal;23225106, 23221232;0.16;Q3;5;19;57;583;25;57;0.4;30.68;Iran;Kermanshah University of Medical Sciences;2012-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biomedical Engineering (Q4); Pharmacology (medical) (Q4)"
575;22908;Chinese Pharmacological Bulletin;journal;10011978;0.158;Q4;15;344;1091;6250;464;1090;0.5;18.17;China;Publication Centre of Anhui Medical University;1993-ongoing;Pharmacology (Q4)
576;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0.158;Q4;8;5;51;368;6;49;0.09;73.60;Netherlands;Brill;1995, 1997, 2001, 2006, 2013-ongoing;"Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Virology (Q4)"
577;21100456601;Journal of Pharmacy and Pharmacognosy Research;journal;07194250;0.158;Q3;5;37;66;1126;33;65;0.29;30.43;Chile;Asociacion Academica de Ciencias Farmaceuticas de Antofagasta (ASOCIFA);2013-ongoing;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
578;19700181240;Global Journal of Pharmacology;journal;19920075;0.157;Q3;13;0;26;0;23;26;0;0.00;Pakistan;International Digital Organization for Scientific Information (IDOSI);2010-2014 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
579;19700175758;International Journal of Drug Development and Research;journal;09759344;0.157;Q3;17;0;124;0;48;124;0.14;0.00;India;International Journal of Drug Development and Research;2010-2015 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
580;21100789875;Proceedings of the 3rd ACM Conference on Systems for Energy-Efficient Built Environments, BuildSys 2016;conference and proceedings;00002016;0.157;-;7;0;51;0;68;49;1.39;0.00;United States;;2016;"Health, Toxicology and Mutagenesis; Toxicology"
581;19700183012;Iranian Journal of Pharmaceutical Sciences;journal;17352444;0.156;Q3;9;16;72;566;26;72;0.25;35.38;Iran;Shiraz University of Medical Sciences;2010-ongoing;"Pharmaceutical Science (Q3); Bioengineering (Q4)"
582;21100265336;International Arabic Journal of Antimicrobial Agents;journal;21749094;0.155;Q4;6;0;14;0;6;14;1;0.00;United Kingdom;Internet Medical Publishing;2011-2015;"Microbiology (medical) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
583;19700188422;Research Journal of Pharmaceutical, Biological and Chemical Sciences;journal;09758585;0.155;Q3;24;0;5072;0;893;5072;0.17;0.00;India;RJPBCS;2010-2016 (cancelled);"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4)"
584;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0.154;Q4;16;18;60;632;29;60;0.36;35.11;India;Natural Remedies Pvt Ltd.;2002-ongoing;Pharmacology (Q4)
585;22854;Yakugaku Zasshi;journal;00316903;0.154;Q3;37;202;598;3879;154;491;0.31;19.20;Japan;Pharmaceutical Society of Japan;1961-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
586;19700174933;Journal of Pharmaceutical Sciences and Research;journal;09751459;0.153;Q3;20;533;637;13152;203;632;0.27;24.68;India;PharmaInfo Publications;2009-ongoing;Pharmaceutical Science (Q3)
587;19381;Acta Farmaceutica Bonaerense;journal;03262383;0.152;Q3;21;0;0;0;0;0;0;0.00;Argentina;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
588;15500154707;International Journal of Biological Chemistry;journal;1819155X;0.152;Q4;12;0;37;0;20;37;0.57;0.00;Pakistan;ANSInet;2009-2016 (cancelled);"Biochemistry (Q4); Pharmacology (Q4)"
589;23171;Korean Journal of Pharmacognosy;journal;02533073;0.152;Q3;14;55;151;1204;43;151;0.29;21.89;South Korea;Korean Society of Pharmacognosy;1990-ongoing;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
590;19700174925;European Pharmaceutical Review;trade journal;13608606;0.151;Q3;7;63;184;334;26;180;0.15;5.30;United Kingdom;Russell Publishing Ltd;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4); Biophysics (Q4); Biotechnology (Q4); Molecular Medicine (Q4)"
591;80593;Journal of Medicinal Plants;journal;16840240;0.151;Q4;16;68;157;2657;51;156;0.26;39.07;Iran;Pizhuhishkadh-i giyahan-i darayiva faravardah ha-vi tabbii;2004-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
592;21100216519;Journal of Pharmaceutical Negative Results;journal;09769234, 22297723;0.151;Q3;5;14;34;232;9;32;0.21;16.57;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
593;21100451405;Natural Products Journal;journal;22103163, 22103155;0.151;Q4;9;39;113;1541;33;102;0.34;39.51;Netherlands;Bentham Science Publishers B.V.;2011-ongoing;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4)"
594;19700188319;International Journal of Pharmaceutical Sciences Review and Research;journal;0976044X;0.149;Q3;24;0;1865;0;488;1865;0.2;0.00;India;Global Research Online;2010-2016 (cancelled);Pharmaceutical Science (Q3)
595;19700201333;International Journal of Drug Delivery;journal;09750215;0.148;Q3;11;0;49;0;29;49;0.67;0.00;United States;Advanced Research Journals;2011-2016 (cancelled);Pharmaceutical Science (Q3)
596;19700201516;Journal of Chemical and Pharmaceutical Sciences;journal;09742115;0.148;Q3;11;0;1571;0;247;1571;0.15;0.00;India;SPB Pharma Society;2010-2016 (cancelled);"Pharmaceutical Science (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Pharmacology (Q4)"
597;22934;Chinese Pharmaceutical Journal;journal;10012494;0.146;Q3;19;392;1266;7968;249;1266;0.19;20.33;China;Zhonogguo Yaoxuehui;1993-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
598;130170;Phytotherapie;journal;17652847, 16248597;0.146;Q4;12;106;221;1600;59;192;0.28;15.09;Germany;Springer Verlag;2005-ongoing;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
599;19700175149;African Journal Biomedical Research;journal;11195096;0.145;Q3;15;48;92;1465;17;90;0.16;30.52;Nigeria;Bioline International;2008, 2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Medicine (miscellaneous) (Q4)"
600;19700175060;International Journal of PharmTech Research;journal;24559563, 09744304;0.145;Q3;40;0;1105;0;763;1105;0.74;0.00;India;Sphinx Knowledge House;2009-2016 (cancelled);"Pharmaceutical Science (Q3); Pharmacology (Q4)"
601;22977;Journal de Pharmacie de Belgique;journal;00472166;0.145;Q3;12;0;54;0;19;53;0.44;0.00;Belgium;Algemene Pharmaceutische Bond;1946-2015;"Pharmaceutical Science (Q3); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
602;19700174931;Asian Journal of Pharmaceutics;journal;1998409X, 09738398;0.144;Q3;16;121;223;3254;64;222;0.27;26.89;India;Medknow Publications;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
603;21798;Farmaceutski Glasnik;journal;00148202;0.144;Q3;5;84;222;828;6;179;0.04;9.86;Croatia;Hrvatsko Farmaceutsko Drustvo/Croatian Pharmaceutical Society;1950-1951, 1962, 1990-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
604;21100782803;Current Psychopharmacology;journal;22115560, 22115579;0.143;Q4;3;0;20;0;5;19;0.26;0.00;Netherlands;Bentham Science Publishers B.V.;2012, 2015-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
605;19700175137;Trends in Medical Research;journal;18193587;0.143;Q3;8;0;39;0;13;39;0.23;0.00;United States;Academic Journals Inc.;2008-2016 (cancelled);"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Medicine (miscellaneous) (Q4)"
606;19700174900;International Journal of Green Pharmacy;journal;19984103, 09738258;0.142;Q3;18;180;177;5999;53;176;0.21;33.33;India;Medknow Publications;2009-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
607;19700188437;Open Access Journal of Medicinal and Aromatic Plants;journal;09747877;0.142;Q4;6;3;12;76;1;12;0.11;25.33;India;Medicinal and Aromatic Plants Association of India;2010-ongoing;"Complementary and Alternative Medicine (Q4); Drug Discovery (Q4)"
608;21100237602;Journal of Pharmacy and Nutrition Sciences;journal;19275951, 22233806;0.141;Q3;8;23;77;761;19;76;0.19;33.09;Canada;Lifescience Global;2011-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health (social science) (Q4); Medicine (miscellaneous) (Q4); Nutrition and Dietetics (Q4)"
609;19700201140;Systematic Reviews in Pharmacy;journal;09758453;0.141;Q3;11;2;30;98;17;30;0.59;49.00;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;Pharmaceutical Science (Q3)
610;5100152606;Biosciences Biotechnology Research Asia;journal;09731245, 24562602;0.139;Q4;13;0;1112;0;364;1112;0.33;0.00;India;Oriental Scientific Pub. Co.;2005-2016 (cancelled);"Agronomy and Crop Science (Q4); Biotechnology (Q4); Drug Discovery (Q4)"
611;19700200724;Der Pharmacia Lettre;journal;09755071;0.139;Q3;24;3;1609;170;450;1609;0.27;56.67;United States;Scholars Research Library;2011-2016 (cancelled);Pharmaceutical Science (Q3)
612;19900194914;Journal of Punjab Academy of Forensic Medicine and Toxicology;journal;0974083X, 09725687;0.139;Q4;6;37;81;581;8;74;0.12;15.70;India;Punjab Academy of Forensic Medicine and Toxicology;2011-ongoing;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
613;19700174997;ONdrugDelivery;trade journal;2049145X;0.139;Q3;5;98;230;409;22;142;0.13;4.17;United Kingdom;Frederick Furness Publishing;2009-ongoing;Pharmaceutical Science (Q3)
614;23107;Journal of Pharmacy Technology;journal;87551225;0.138;Q3;9;32;120;711;23;118;0.21;22.22;United States;SAGE Publications Inc.;1989-ongoing;Pharmaceutical Science (Q3)
615;19700175006;Thai Journal of Pharmaceutical Sciences;journal;01254685;0.138;Q3;11;27;126;752;29;126;0.19;27.85;Thailand;Chulalongkorn University;2009-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
616;21100242405;Marmara Pharmaceutical Journal;journal;13090801;0.137;Q3;10;95;114;3178;43;114;0.38;33.45;Turkey;Marmara University;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)"
617;19700188484;Journal of Bioequivalence and Bioavailability;journal;09750851;0.136;Q3;10;0;30;0;10;22;0;0.00;India;OMICS Publishing Group;2011-2014 (cancelled);Pharmaceutical Science (Q3)
618;19700174632;Journal of Receptor, Ligand and Channel Research;journal;1178699X;0.136;Q4;7;0;16;0;11;15;0.67;0.00;United Kingdom;Dove Medical Press Ltd;2010-ongoing;"Biochemistry (Q4); Biophysics (Q4); Cell Biology (Q4); Pharmacology (Q4)"
619;19900192173;International Journal of Pharmaceutical and Clinical Research;journal;09751556;0.135;Q3;9;0;379;0;136;379;0.36;0.00;Australia;International Journal of Pharmaceutical and Clinical Research;2011-2016 (cancelled);"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (medical) (Q4)"
620;4000148308;Chinese Traditional and Herbal Drugs;journal;02532670;0.134;Q3;13;787;2017;14434;383;1995;0.17;18.34;China;Chung Tsao Yao Tsa Chih Pien Chi Pu;2006-ongoing;"Pharmaceutical Science (Q3); Complementary and Alternative Medicine (Q4); Drug Discovery (Q4); Pharmacology (medical) (Q4)"
621;19700174924;Biomedical and Pharmacology Journal;journal;09746242, 24562610;0.132;Q4;12;267;653;7008;139;653;0.16;26.25;India;Oriental Scientific Pub. Co.;2009-ongoing;Pharmacology (Q4)
622;73076;Drug Discovery World;journal;14694344;0.132;Q4;10;27;102;337;22;90;0.15;12.48;United Kingdom;R J Communications & Media World Ltd.;2004-ongoing;Drug Discovery (Q4)
623;19700175858;Journal of Pharmacognosy and Phytotherapy;journal;21412502;0.132;Q4;18;1;51;26;177;51;4.03;26.00;Nigeria;Academic Journals;2010-2016 (cancelled);Drug Discovery (Q4)
624;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X, 23006676;0.131;Q4;7;40;157;1018;35;157;0.25;25.45;Poland;Uniwersytet Medyczny w Lublinie;2012-ongoing;"Biochemistry (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
625;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.131;Q3;14;143;136;95;34;136;0.06;0.66;Brazil;Universidade Estadual Paulista (UNESP);2005-ongoing;Pharmaceutical Science (Q3)
626;6400153143;Turkish Journal of Pharmaceutical Sciences;journal;1304530X;0.131;Q3;11;46;115;1826;37;112;0.26;39.70;Turkey;Turkish Pharmacists Association;2006-ongoing;"Pharmaceutical Science (Q3); Molecular Medicine (Q4)"
627;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.13;Q4;11;16;74;0;13;74;0.13;0.00;Japan;Nihon Sangyo Eisei Gakkai;1995-ongoing;"Medicine (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
628;9100153105;Current Topics in Pharmacology;journal;09724559;0.129;Q4;4;12;24;476;5;24;0.23;39.67;India;Research Trends;2006-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
629;21100804474;European Pharmaceutical Journal;journal;24536725;0.129;Q3;5;17;58;339;14;53;0.27;19.94;Germany;de Gruyter;2016-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
630;22375;Indian Drugs;journal;0019462X;0.129;Q3;30;118;273;2634;27;273;0.1;22.32;India;Scientific Publishers;1989-ongoing;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
631;21100465007;International Research Journal of Pharmacy;journal;22308407;0.129;Q3;0;0;0;0;0;0;0;0.00;India;Moksha Publishing House;2012, 2014-ongoing;Pharmaceutical Science (Q3)
632;21100244805;Journal of Vaccines and Vaccination;journal;21577560;0.129;Q4;9;0;31;0;7;29;0;0.00;India;OMICS Publishing Group;2010-2014 (cancelled);"Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Virology (Q4)"
633;144613;Journal of Generic Medicines;journal;17411343;0.128;Q3;14;30;47;447;5;39;0.13;14.90;United Kingdom;SAGE Publications Inc.;2003-2017 (cancelled), 2017-2017 (cancelled);Pharmaceutical Science (Q3)
634;25197;Revista de Toxicologia;journal;16970748, 02127113;0.128;Q4;9;32;57;637;14;52;0.26;19.91;Spain;Asociacion Espanola de Toxicologia;1989-2017 (cancelled);Toxicology (Q4)
635;21265;Drugs of the Future;journal;03778282;0.127;Q4;40;85;309;1715;35;301;0.15;20.18;Spain;Prous Science;1978-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
636;73430;Pharmaceutical Technology;journal;15432521;0.127;Q3;35;239;516;1080;56;312;0.32;4.52;United States;UBM Medica Periodical Publication;1979-1985, 1987, 1996-ongoing;"Pharmaceutical Science (Q3); Biophysics (Q4)"
637;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.127;Q4;11;16;133;442;25;129;0.14;27.63;Cuba;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-ongoing;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
638;19700200880;Botulinum Journal;journal;17547326;0.126;Q3;5;0;6;0;3;6;0.5;0.00;Switzerland;Inderscience Publishers;2009-2013, 2016-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4); Cellular and Molecular Neuroscience (Q4)"
639;21100197160;Research Journal of Pharmacy and Technology;journal;09743618, 0974360X;0.126;Q3;14;584;965;13298;134;963;0.15;22.77;India;A and V Publication;2011-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)"
640;21100784631;AIAA Modeling and Simulation Technologies Conference, 2015;conference and proceedings;00002015;0.123;-;0;0;1;0;0;1;0;0.00;United States;;2015;"Bioengineering; Drug Discovery"
641;25253;Blutalkohol;journal;00065250;0.123;Q4;13;23;100;216;5;85;0.07;9.39;Germany;Springer Verlag;1974-2017 (cancelled);"Medicine (miscellaneous) (Q4); Toxicology (Q4)"
642;21100349120;Cancer Drug Discovery and Development;book series;21969914;0.123;Q4;0;0;0;0;0;0;0;0.00;United States;Humana Press Inc.;2015;"Cancer Research (Q4); Drug Discovery (Q4); Oncology (Q4)"
643;17700156434;Current Pharmacogenomics and Personalized Medicine;journal;18756913, 18756921;0.123;Q4;17;16;56;1195;7;52;0.06;74.69;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Genetics (Q4); Genetics (clinical) (Q4); Molecular Biology (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
644;17300154738;Current Trends in Biotechnology and Pharmacy;journal;09738916;0.123;Q4;10;24;122;907;22;122;0.19;37.79;India;Association of Biotechnology and Pharmacy;2009-ongoing;"Biotechnology (Q4); Drug Discovery (Q4); Pharmaceutical Science (Q4)"
645;20500195212;International Journal of Drug Delivery Technology;journal;09754415;0.123;Q3;7;40;42;1065;12;42;0.23;26.63;Australia;International Journal of Drug Delivery Technology;2011-ongoing;Pharmaceutical Science (Q3)
646;21100241763;International Journal of Green Nanotechnology;journal;19430906, 19430892;0.123;Q4;3;0;1;0;0;1;0;0.00;United Kingdom;Taylor and Francis Inc.;2011-2014;"Biomedical Engineering (Q4); Chemistry (miscellaneous) (Q4); Electrical and Electronic Engineering (Q4); Materials Science (miscellaneous) (Q4); Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4)"
647;19700175049;Internet Journal of Toxicology;journal;15593916;0.123;Q4;5;0;1;0;0;1;0;0.00;United States;Internet Scientific Publications;2009-2011, 2013, 2015;Toxicology (Q4)
648;22906;Journal of China Pharmaceutical University;journal;10005048;0.123;Q4;13;90;365;2254;50;365;0.13;25.04;China;China Pharmaceutical University;1989-1991, 2002-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
649;19700175105;Open Drug Delivery Journal;journal;18741266;0.123;Q3;5;0;1;0;0;1;0;0.00;United Arab Emirates;Bentham Science Publishers;2009-2010, 2014;Pharmaceutical Science (Q3)
650;21100205919;Open Drug Discovery Journal;journal;18773818;0.123;Q4;8;0;1;0;0;1;0;0.00;United Arab Emirates;Bentham Science Publishers;2010, 2014;Drug Discovery (Q4)
651;19700201609;Open Natural Products Journal;journal;18748481;0.123;Q4;3;0;1;0;0;1;0;0.00;Netherlands;Bentham Science Publishers B.V.;2011-2014;"Complementary and Alternative Medicine (Q4); Drug Discovery (Q4)"
652;21100853008;Pharmacie Globale;journal;09768157;0.123;Q3;0;0;1;0;0;1;0;0.00;India;Pharmacie Globale;2015;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)"
653;70864;Anales de la Real Academia Nacional de Farmacia;journal;1697428X, 16974271;0.122;Q4;8;50;122;2083;17;109;0.2;41.66;Spain;Real Academia Nacional de Farmacia;2004-2005;"Cell Biology (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
654;13000154717;Current Topics in Toxicology;journal;09728228;0.122;Q4;6;12;31;449;6;31;0.25;37.42;India;Research Trends;2007-2009, 2011-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
655;21100293201;International Journal of Research in Ayurveda and Pharmacy;journal;22774343, 22293566;0.122;Q4;8;0;148;0;43;148;0.47;0.00;India;Moksha Publishing House;2012-2016 (cancelled);"Drug Discovery (Q4); Pharmaceutical Science (Q4)"
656;19700175098;Klinicka Farmakologie a Farmacie;journal;12127973, 18035353;0.122;Q4;4;29;129;591;9;112;0.06;20.38;Czech Republic;SOLEN s.r.o.;2009-ongoing;"Pharmacy (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4)"
657;21127;Pharmaceutical Technology Europe;journal;17537967;0.122;Q4;16;136;446;595;13;378;0.02;4.38;United States;Advanstar Communications Inc.;1998-ongoing;Pharmaceutical Science (Q4)
658;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.121;Q4;13;101;300;1505;48;300;0.18;14.90;Russian Federation;Izdatel'stvo Meditsina Publishers;1992-ongoing;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4)"
659;19430;Adverse Drug Reaction Bulletin;journal;00446394;0.12;Q4;7;8;17;214;5;17;0.17;26.75;United States;Lippincott Williams & Wilkins Ltd.;1970, 1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
660;19700182629;Methods in Pharmacology and Toxicology;book series;15572153;0.12;Q4;6;13;173;615;42;120;0.48;47.31;United States;Humana Press, Inc.;2008, 2012-ongoing;"Molecular Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
661;19700175031;Research Journal of Pharmacology;journal;18159362, 19936109;0.12;Q4;7;0;10;0;3;10;0;0.00;Pakistan;Medwell Online;2008-2016 (cancelled);"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
662;17600155051;Drug Delivery Technology;trade journal;15372898;0.119;Q4;9;69;243;399;13;116;0.09;5.78;United States;Drug Delivery Technology, LLC;2009-ongoing;Pharmaceutical Science (Q4)
663;19700201471;International Journal of Pharmacy and Technology;journal;0975766X;0.119;Q4;15;0;2269;0;363;2266;0.16;0.00;India;International Journal of Pharmacy and Technology(IJPT);2011-2016 (cancelled);"Biomedical Engineering (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
664;19700201521;Journal of Chemical and Pharmaceutical Research;journal;09757384;0.119;Q4;29;0;2367;0;515;2366;0.22;0.00;India;JOCPR;2011-2014 (cancelled);Pharmaceutical Science (Q4)
665;19700175778;International Journal of Research in Pharmaceutical Sciences;journal;09757538;0.117;Q4;15;109;143;2834;19;143;0.1;26.00;India;JK Welfare & Pharmascope Foundation;2010-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
666;22514;Japanese Journal of Chemotherapy;journal;13407007;0.117;Q4;12;28;60;785;7;60;0.1;28.04;Japan;Nihon Kagaku Ryoho Gakkai/Japan Society of Chemotherapy;1995-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
667;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.117;Q4;13;138;323;2185;23;321;0.07;15.83;Japan;Life Science Publishing Co. Ltd.;1981-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
668;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.116;Q4;11;143;447;5170;50;394;0.11;36.15;China;Chung-Kuo Yao Li Hseuh Hui;1986-ongoing;"Pharmacology (Q4); Toxicology (Q4)"
669;20400195018;International Journal of Pharmacognosy and Phytochemical Research;journal;09754873;0.116;Q4;14;0;716;0;300;716;0.47;0.00;India;International Journal of Pharmacognosy and Phytochemical Research;2011-2016 (cancelled);Drug Discovery (Q4)
670;19700188355;International Journal of Phytomedicine;journal;09750185;0.116;Q4;15;0;161;0;22;161;0.13;0.00;United States;Advanced Research Journals;2010-2016 (cancelled);"Complementary and Alternative Medicine (Q4); Drug Discovery (Q4)"
671;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;03881601;0.116;Q4;7;34;102;269;4;97;0.06;7.91;Japan;Nihon Rinsho Yakuri Gakkai/Japanese Society of Clinical Pharmacology and Therapeutics;1987-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
672;4700151603;Journal of Pharmacy of Istanbul University;journal;03677524;0.115;Q4;7;0;29;0;8;28;0.29;0.00;Turkey;Istanbul Universitesi Eczacilik Fakultesi;2005, 2007-2008, 2010, 2012, 2015-ongoing;"Pharmacy (Q3); Pharmaceutical Science (Q4)"
673;19700174940;SA Pharmaceutical Journal;journal;10151362;0.115;Q4;6;76;300;846;22;215;0.11;11.13;South Africa;Medpharm Publications Ltd.;2009-ongoing;Pharmaceutical Science (Q4)
674;21100291830;Selenium in the Environment and Human Health - Proceedings of the 3rd International Conference on Selenium in the Environment and Human Health;conference and proceedings;00002014;0.115;-;4;0;92;0;10;90;0;0.00;Netherlands;;2014;"Health, Toxicology and Mutagenesis; Toxicology"
675;21000195625;Asian Journal of Pharmaceutical Research and Health Care;journal;22501444, 22501460;0.114;Q4;4;0;44;0;18;44;0.34;0.00;India;Journal of Pharmaceutical Research and Health Care;2011-2016 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
676;4000148821;International Journal of Pharmaceutical Compounding;journal;10924221;0.114;Q4;9;66;223;0;45;213;0.19;0.00;United States;International Journal of Pharmaceutical Compounding (Ijpc);2006-ongoing;"Pharmacology (nursing) (Q3); Pharmacy (Q3); Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
677;5900153315;Pharmacoeconomics - Spanish Research Articles;journal;1695405X;0.114;Q4;5;13;49;405;5;47;0.07;31.15;Switzerland;Springer International Publishing AG;2007-ongoing;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
678;19700194018;Russian Journal of Biopharmaceuticals;journal;20738099;0.114;Q4;4;45;135;690;17;134;0.12;15.33;Russian Federation;Folium Publishing Company;2011-ongoing;"Bioengineering (Q4); Drug Discovery (Q4)"
679;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.113;Q4;17;94;349;1788;30;252;0.12;19.02;Japan;Nippon Yakuri Gakkai;1961-ongoing;Pharmacology (Q4)
680;21100455612;2015 4th International Conference on Future Generation Communication Technology, FGCT 2015;conference and proceedings;00002015;0.112;-;4;0;30;0;22;28;0.79;0.00;United States;;2015;"Health, Toxicology and Mutagenesis; Pollution; Toxicology"
681;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0.112;Q4;14;22;12;1286;1;12;0;58.45;Turkey;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-ongoing;Pharmaceutical Science (Q4)
682;21100853531;Indian Journal of Novel Drug Delivery;journal;09755500;0.111;Q4;0;0;2;0;0;2;0;0.00;India;Karnataka Education and Scientific Society;2015-ongoing;Pharmaceutical Science (Q4)
683;21100790356;International Journal of Life Sciences Biotechnology and Pharma Research;journal;22503137;0.111;Q4;1;0;2;0;0;2;0;0.00;India;IJLBPR Editorial Office;2012, 2014, 2016-ongoing;"Applied Microbiology and Biotechnology (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
684;21100785532;International Journal of Pharma Medicine and Biological Sciences;journal;22785221;0.111;Q4;1;0;3;0;0;3;0;0.00;India;International Journal of Pharma Medicine and Biological Sciences;2012, 2016-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
685;19700175056;Jordan Journal of Pharmaceutical Sciences;journal;19957157;0.111;Q4;8;5;52;175;7;52;0.12;35.00;Jordan;University of Jordan;2009-ongoing;Pharmaceutical Science (Q4)
686;19700188309;Journal of Bioanalysis and Biomedicine;journal;1948593X;0.111;Q4;9;0;3;0;0;2;0;0.00;India;OMICS Publishing Group;2010-2014 (cancelled);Pharmaceutical Science (Q4)
687;19700177006;Psychopharm Review;trade journal;19369255;0.111;Q4;4;0;2;0;0;2;0;0.00;United States;Lippincott Williams & Wilkins Ltd.;2009-2014;"Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
688;20628;Circular Farmaceutica;journal;00097314;0.11;Q4;2;24;90;189;1;76;0;7.88;Spain;Colegio Official de Farmaceuticos de la Provincia de Barcelona;1961, 1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
689;21823;Farmatsija;journal;04280296;0.11;Q4;5;22;75;592;11;75;0.04;26.91;Bulgaria;Meditsinski Universitet - Sofia;1945, 1954-1955, 1987-1991, 1997-ongoing;"Pharmacy (Q3); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
690;21100301409;Issues in Toxicology;book series;17577179;0.11;Q4;12;35;169;3257;25;85;0.56;93.06;United Kingdom;Royal Society of Chemistry;2007-ongoing;"Health, Toxicology and Mutagenesis (Q4); Pharmacology (Q4); Toxicology (Q4)"
691;19700174645;Journal of International Pharmaceutical Research;journal;16740440;0.11;Q4;8;35;156;892;14;156;0.05;25.49;India;Journal of International Pharmaceutical Research;2010-ongoing;"Pharmaceutical Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
692;21716;Pharmazeutische Zeitung;journal;00317136;0.11;Q4;7;791;2233;890;6;1488;0;1.13;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
693;19399;Acta Pharmaceutica Hungarica;journal;00016659;0.109;Q4;12;9;50;306;6;50;0.13;34.00;Hungary;Magyar Gyogyszereszeti Tarsasag/Hungarian Pharmaceutical Association;1965-ongoing;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4)"
694;21100199794;Industrial Pharmacy;trade journal;17414911;0.109;Q4;4;0;31;0;2;31;0.13;0.00;United Kingdom;Euromed Communications Ltd;2011-ongoing;Pharmaceutical Science (Q4)
695;19700201509;Pharma Research;journal;09758216;0.109;Q4;4;0;27;0;3;27;0.3;0.00;India;Sudarshan Publications;2011-2016 (cancelled);"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
696;22358;U.S. Pharmacist;journal;01484818;0.109;Q4;7;112;497;1973;29;362;0.07;17.62;United States;Jobson Publishing LLC;1979, 1990-1996, 2007-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
697;19700174922;Chinese Journal of New Drugs;journal;10033734;0.108;Q4;9;519;1614;7174;107;1614;0.06;13.82;China;Chinese Journal of New Drugs Co. Ltd.;2008-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
698;21100202909;Drug Invention Today;journal;09757619;0.108;Q4;12;29;6;749;1;6;0;25.83;India;Association of Pharmaceutical Innovators;2012-ongoing;Drug Discovery (Q4)
699;19700174987;Research Journal of Toxins;journal;18193560;0.108;Q4;2;0;3;0;0;3;0;0.00;United States;Academic Journals Inc.;2009, 2014-2016 (cancelled);"Agronomy and Crop Science (Q4); Food Science (Q4); Toxicology (Q4)"
700;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0.108;Q4;8;0;63;0;6;51;0.12;0.00;Mexico;Asociacion Farmaceutica Mexicana;1997-2015;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
701;19700170837;Vitae;journal;01214004;0.108;Q4;11;18;352;596;19;257;0.03;33.11;Colombia;Universidad de Antioquia;2009-ongoing;"Applied Microbiology and Biotechnology (Q4); Bioengineering (Q4); Biotechnology (Q4); Food Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
702;19978;Ars Pharmaceutica;journal;00042927, 23409894;0.107;Q4;18;23;103;609;14;99;0.19;26.48;Spain;Editorial Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017 (cancelled);"History and Philosophy of Science (Q4); Pharmaceutical Science (Q4)"
703;19700174811;European Journal of Parenteral and Pharmaceutical Sciences;journal;17406277;0.107;Q4;5;0;36;0;5;26;0.27;0.00;United Kingdom;Euromed Communications Ltd;2010-2015;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
704;21100205709;International Journal of Toxicological and Pharmacological Research;journal;09755160;0.107;Q4;8;0;142;0;38;142;0.27;0.00;Australia;International Journal of Toxicological and Pharmacological Research;2011-2016 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
705;50105;Japanese Journal of Neuropsychopharmacology;journal;13434144;0.107;Q4;9;26;45;487;7;44;0.2;18.73;Japan;Nihon Shinkei Seishin Yakuri Gakkai/Japanese Society of Neuropsychophamacology;1982-1997, 2002-ongoing;"Clinical Psychology (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
706;15323;Journal of Jilin University Medicine Edition;journal;1671587X;0.107;Q4;5;250;520;3310;45;520;0.09;13.24;China;Jilin University;2005-ongoing;Pharmacology (Q4)
707;21083;Pharmaceutical Care Espana;journal;11396202;0.107;Q4;9;1;105;5;5;84;0.08;5.00;Spain;Fundacion Pharamaceutical Care Espana;2001-2016 (cancelled);"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
708;18098;Japanese Journal of Psychopharmacology;journal;13402544;0.106;Q4;11;0;15;0;0;15;0;0.00;Japan;Nihon Shinkei Seishin Yakuri Gakkai/Japanese Society of Neuropsychophamacology;1981-2017;"Clinical Psychology (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
709;15842;Journal of Applied Research;journal;1537064X;0.106;Q4;18;0;4;0;0;4;0;0.00;United States;Therapeutic Solutions LLC;2001-2014;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
710;24097;Journal of the Indian Chemical Society;journal;00194522;0.105;Q4;31;144;752;5153;133;752;0.18;35.78;India;Scientific Publishers;1973-1985, 1987-1991, 1996-ongoing;"Drug Discovery (Q4); Electrochemistry (Q4); Inorganic Chemistry (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
711;21100398550;Orphan Drugs: Research and Reviews;journal;22306161;0.105;Q4;2;4;12;323;3;12;0.3;80.75;New Zealand;Dove Medical Press Ltd.;2017-ongoing, 2014-ongoing;"Drug Discovery (Q4); Pharmaceutical Science (Q4)"
712;19700174966;Pharmakeftiki;journal;11054999;0.105;Q4;2;4;28;150;1;28;0.06;37.50;Greece;Papathanasopoulos;2008-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
713;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0.104;Q4;15;32;7;1000;1;7;0.14;31.25;Turkey;Istanbul Medipol University;2006-2011, 2016-ongoing;Pharmaceutical Science (Q4)
714;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0.104;Q4;9;7;21;222;0;21;0;31.71;Turkey;Ankara Universitesi;1997-2001, 2003-2010, 2014, 2016-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
715;21100853005;Applied Clinical Research, Clinical Trials and Regulatory Affairs;journal;2213476X, 22134778;0.104;Q4;0;0;0;0;0;0;0;0.00;Netherlands;Bentham Science Publishers B.V.;2014-ongoing;"Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Pharmacology (medical) (Q4)"
716;19700171709;Arhiv za Farmaciju;journal;00041963, 22178767;0.104;Q4;3;7;82;130;4;76;0.03;18.57;Serbia;Farmaceutsko Drustvo Srbije;1954-1955, 2009-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
717;19700175108;Drug Delivery System;journal;09135006;0.104;Q4;7;62;186;822;4;124;0.02;13.26;Japan;Japan Society of Drug Delivery System;2009-ongoing;Pharmaceutical Science (Q4)
718;21100853528;International Journal of Advances in Pharmaceutical Research;journal;22307583, 22497226;0.104;Q4;0;0;6;0;0;6;0;0.00;India;International Journal of Advances in Pharmaceutical Research;2014-2015;"Drug Discovery (Q4); Pharmaceutical Science (Q4)"
719;19700200708;Journal of Global Pharma Technology;journal;09758542;0.104;Q4;10;205;100;5988;48;100;0.51;29.21;India;Journal of Global Pharma Technology;2010-ongoing;Pharmaceutical Science (Q4)
720;11200153306;Journal of Pharmacology and Toxicology;journal;1816496X;0.104;Q4;15;6;24;261;5;24;0.08;43.50;United States;Academic Journals Inc.;2008-2016 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
721;19700174892;Chinese Journal of Cancer Biotherapy;journal;1007385X;0.103;Q4;3;0;314;0;11;296;0.03;0.00;China;Chinese Journal of Cancer Biotheraphy;2008-ongoing;"Cancer Research (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
722;21100829255;Chinese Journal of Pharmaceutical Biotechnology;journal;10058915;0.103;Q4;4;119;386;2045;11;386;0.02;17.18;China;China Pharmaceutical University;2007-ongoing;"Applied Microbiology and Biotechnology (Q4); Pharmaceutical Science (Q4)"
723;21238;Drug Topics;journal;00126616;0.103;Q4;7;159;835;50;8;126;0.06;0.31;United States;Advanstar Communications Inc.;1991, 1997-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
724;19700174992;European Journal of Oncology Pharmacy;journal;20327072, 17833914;0.103;Q4;3;9;50;102;2;28;1;11.33;Belgium;Pharma Publishing and Media Europe;2008-ongoing;"Oncology (Q4); Pharmacology (Q4)"
725;21100853529;International Journal of Pharmaceutical and Phytopharmacological Research;journal;22496084, 22501029;0.103;Q4;1;0;7;0;0;7;0;0.00;India;International Journal of Pharmaceutical and Phytopharmacological Research;2014-2015;"Drug Discovery (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
726;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.103;Q4;5;13;27;223;1;27;0.05;17.15;Japan;Shika Yakubutsu Ryoho Kenkyukai;1984-ongoing;"Dentistry (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
727;21102;Pharmaceutical Journal;journal;00316873;0.103;Q4;25;72;1005;317;25;273;0.1;4.40;United Kingdom;Pharmaceutical Press;1945-1949, 1994-2012, 2014-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
728;21243;Pharmacy times;trade journal;00030627;0.103;Q4;8;238;792;1231;10;249;0.07;5.17;United States;Romaine Pierson Publishers;1947-1949, 1975, 1977-1987, 2007-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
729;5200152604;Pharma Times;journal;00316849;0.103;Q4;10;81;257;651;12;119;0.03;8.04;India;Indian Pharmaceutical Association;2006-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
730;21100446017;Proceedings of the 16th International Association for Mathematical Geosciences - Geostatistical and Geospatial Approaches for the Characterization of Natural Resources in the Environment: Challenges, Processes and Strategies, IAMG 2014;conference and proceedings;00002014;0.103;-;2;0;148;0;9;146;0;0.00;India;;2014;"Organic Chemistry; Pharmaceutical Science"
731;5800207507;Side Effects of Drugs Annual;book series;03786080;0.103;Q4;5;49;203;3005;11;0;0;61.33;Netherlands;Elsevier BV;1977-1995, 1997-2005, 2007-ongoing;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
732;21100812583;ACM International Conference Proceeding Series;conference and proceedings;00002016;0.102;-;1;0;13;0;1;11;0.09;0.00;United States;;2016;"Organic Chemistry; Pharmaceutical Science"
733;21100818733;Archives of Pharmacy Practice;journal;2045080X;0.102;Q4;2;0;6;0;0;6;0;0.00;India;Medknow Publications and Media Pvt. Ltd;2016-ongoing;Pharmaceutical Science (Q4)
734;21100204921;Bulletin of Pharmaceutical Sciences;journal;11100052;0.102;Q4;7;0;9;0;0;9;0;0.00;Egypt;Faculty of Pharmacy, Assiut University;2008-2013;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
735;22887;Chinese Journal of Antibiotics;journal;10018689;0.102;Q4;10;0;297;0;12;297;0.04;0.00;China;Editorial Office of the Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
736;21100202747;GMP Review;trade journal;14764547;0.102;Q4;2;9;11;37;0;11;0;4.11;United Kingdom;Euromed Communications Ltd;2011-2015;Pharmaceutical Science (Q4)
737;21100853580;International Journal of Pharmaceutical Research and Allied Sciences;journal;22773657;0.102;Q4;0;0;0;0;0;0;0;0.00;India;International Journal of Pharmaceutical Research and Allied Sciences;2015-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
738;11100153311;Iranian Journal of Pharmacology and Therapeutics;journal;17352657;0.102;Q4;18;0;11;0;0;11;0;0.00;Iran;Razi Institute for Drug Research of IUMS;2006-2015;Pharmacology (Q4)
739;21100853545;Journal of Global Trends in Pharmaceutical Sciences;journal;22307346;0.102;Q4;0;0;9;0;0;9;0;0.00;India;Annamacharya College of Pharmacy;2015-ongoing;"Molecular Medicine (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
740;19700201410;Milestones in Drug Therapy;book series;22966056;0.102;Q4;4;8;29;621;1;14;0;77.63;United States;Springer Science + Business Media;2010-ongoing;"Drug Discovery (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
741;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0.102;Q4;9;8;70;184;4;62;0.05;23.00;Netherlands;IOS Press;2010-ongoing;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
742;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0.101;Q4;6;0;34;0;0;34;0;0.00;Spain;Real Academia Nacional de Medicina;1949-2011;"Cell Biology (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
743;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074;0.101;Q4;9;3;29;79;0;26;0;26.33;India;Anil Aggrawal;2000-ongoing;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
744;9800153152;Archivos Venezolanos de Farmacologia y Terapeutica;journal;07980264;0.101;Q4;4;41;21;1631;0;21;0;39.78;Venezuela;Tribuna Medica Venezolana;2007-2013, 2015-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
745;21100781407;EMC Seattle 2016 - 34th Annual West Coast Energy Management Congress;conference and proceedings;00002016;0.101;-;0;0;29;0;0;28;0;0.00;Hong Kong;;2016;"Health, Toxicology and Mutagenesis; Pollution; Toxicology"
746;21800;Farmacevtski Vestnik;journal;00148229;0.101;Q4;4;0;179;0;1;167;0.01;0.00;Slovenia;Slovensko Farmacevtsko Drustvo;1961, 1989-2016 (cancelled);"Pharmaceutical Science (Q4); Pharmacology (Q4)"
747;21100204506;International Journal of Pharmaceutical Quality Assurance;journal;09759506;0.101;Q4;5;33;37;786;2;37;0.06;23.82;India;In-IJPQA;2011, 2013-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
748;19700175034;Pharmaceutical Processing;trade journal;10499156;0.101;Q4;2;37;98;16;0;25;0;0.43;United States;Advantage Business Media;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
749;19700175580;PharmacoVigilance Review;journal;17526752;0.101;Q4;1;8;31;10;1;24;0.05;1.25;United Kingdom;Euromed Communications Ltd;2010-ongoing;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
750;21100812575;Process Development Division 2016 - Core Programming Area at the 2016 AIChE Meeting;conference and proceedings;00002016;0.101;-;0;0;20;0;0;19;0;0.00;United States;;2016;"Bioengineering; Food Science; Pharmaceutical Science"
751;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.101;Q4;8;44;183;1022;21;172;0.05;23.23;Cuba;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
752;16800154712;Sp2;trade journal;1476184X;0.101;Q4;1;0;37;0;0;34;0;0.00;United Kingdom;Manor Creative;2009-2014;"Drug Discovery (Q4); Molecular Medicine (Q4)"
753;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.101;Q4;9;5;37;62;0;37;0;12.40;France;Editions de Sante;1991-2014, 2017-ongoing;Pharmaceutical Science (Q4)
754;19900195040;Therapeutics, Pharmacology and Clinical Toxicology;journal;15830012;0.101;Q4;3;0;63;0;1;62;0.03;0.00;Romania;Rp Publishing House;2011-2012, 2014-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
755;21100463816;39th International Precious Metals Conference: Charting Precious Metals through the Changing Currents of Compliance, Finance, Consumer Trends, Risk and New Technology, IPMI 2015;conference and proceedings;00002015;0.1;-;1;0;56;0;0;55;0;0.00;United States;;2015;"Organic Chemistry; Pharmaceutical Science"
756;19700174886;Arzneimitteltherapie;journal;07236913;0.1;Q4;6;153;529;994;4;227;0.03;6.50;Germany;Wissenschaftliche Verlagsgesellschaft;2008-ongoing;"Pharmacology (medical) (Q4); Pharmacology (nursing) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
757;19700175121;Azerbaijan Pharmaceutical and Pharmacotherapy Journal;journal;19941951;0.1;Q4;2;17;52;62;1;52;0;3.65;Azerbaijan;Azarbaucan Tibb Universiteti;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
758;50087;EBR - European Biopharmaceutical Review;journal;13690663;0.1;Q4;5;29;122;191;0;106;0;6.59;United Kingdom;Samedan Ltd.;2004-ongoing;Pharmaceutical Science (Q4)
759;21334;EPC - European Pharmaceutical Contractor;journal;1364369X;0.1;Q4;3;0;104;0;0;97;0;0.00;United Kingdom;Samedan Ltd.;2002-ongoing;Pharmaceutical Science (Q4)
760;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.1;Q4;4;15;62;406;0;58;0;27.07;Bulgaria;Pharmakon Press;1989-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
761;21795;Farmaceuticky Obzor;journal;00148172;0.1;Q4;7;0;54;0;0;50;0;0.00;Slovakia;Ministerstvo Zdravotnictva;1961-1963, 1974, 1976-2016 (cancelled);Pharmaceutical Science (Q4)
762;21867;Geneesmiddelenbulletin;journal;03044629;0.1;Q4;6;33;137;442;0;103;0;13.39;Netherlands;Stichting Geneesmiddelenbulletin;1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
763;10600153336;Innovations in Pharmaceutical Technology;trade journal;14717204;0.1;Q4;6;29;127;119;0;126;0;4.10;United Kingdom;Samedan Pharmaceutical Publishers Ltd.;2007-2010, 2012-ongoing;Pharmaceutical Science (Q4)
764;13637;Manufacturing Chemist;journal;02624230;0.1;Q4;6;46;134;112;0;124;0;2.43;United Kingdom;Polygon Media Ltd.;1981-1984, 1986, 1989, 1996-2001, 2006-ongoing;Pharmaceutical Science (Q4)
765;21100407623;Multimedia Technology IV - Proceedings of the 4th International Conference on Multimedia Technology;conference and proceedings;00002015;0.1;-;2;0;43;0;2;42;0.05;0.00;Netherlands;;2015;"Health, Toxicology and Mutagenesis; Toxicology"
766;19700181430;Pharmaceutical Manufacturing and Packing Sourcer;trade journal;14631245;0.1;Q4;3;0;148;0;0;147;0;0.00;United Kingdom;Samedan Pharmaceutical Publishers Ltd.;2009-ongoing;"Pharmaceutical Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
767;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0.1;Q4;5;97;152;297;1;125;0.01;3.06;United States;Russell Publishing LLC;2010-ongoing;"Health Policy (Q4); Pharmaceutical Science (Q4)"
768;12100156730;Pharmaceutische Weekblad Wetenschappelijk Platform;journal;18738982;0.1;Q4;2;0;134;0;0;115;0;0.00;Netherlands;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);2008, 2013-2015;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
769;21142;Pharmaceutisch Weekblad;journal;00316911;0.1;Q4;9;441;1164;416;2;699;0;0.94;Netherlands;Royal Netherlands Pharmaceutical Society;1948-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
770;20572;PZ Prisma;journal;09455566;0.1;Q4;5;35;99;912;0;85;0;26.06;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1994-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
771;21100841779;ADMET and DMPK;journal;18487718;;-;9;22;80;1135;50;75;0.65;51.59;Croatia;International Association of Physical Chemists;2017-ongoing;"Health (social science); Pharmacology (medical)"
772;21100854647;Applied In Vitro Toxicology;journal;23321512, 23321539;;-;2;5;2;408;7;2;3.5;81.60;United States;Mary Ann Liebert Inc.;2015-ongoing;"Health, Toxicology and Mutagenesis; Medical Laboratory Technology; Toxicology"
773;21100811517;Birth Defects Research;journal;24721727;;-;7;139;0;7813;0;0;0;56.21;United Kingdom;John Wiley and Sons Ltd;2017-ongoing;"Developmental Biology; Embryology; Health, Toxicology and Mutagenesis; Pediatrics, Perinatology and Child Health; Toxicology"
774;21100829975;Clinical and Experimental Vaccine Research;journal;2287366X, 22873651;;-;5;21;0;763;0;0;0;36.33;South Korea;Korean Vaccine Society;2017-ongoing;"Immunology and Allergy; Infectious Diseases; Pharmacology; Public Health, Environmental and Occupational Health"
775;21100854830;Clinical Phytoscience;journal;21991197;;-;2;2;2;169;0;2;0;84.50;Switzerland;Springer International Publishing AG;2015, 2017-ongoing;"Complementary and Alternative Medicine; Pharmacology; Plant Science"
776;21100824046;Computational Toxicology;journal;24681113;;-;5;21;0;1061;0;0;0;50.52;Netherlands;Elsevier BV;2017-ongoing;"Computer Science Applications; Health, Toxicology and Mutagenesis; Toxicology"
777;21100857212;Current Opinion in Systems Biology;journal;24523100;;-;6;119;0;6835;0;0;0;57.44;United Kingdom;Elsevier Ltd;2017-ongoing;"Applied Mathematics; Biochemistry, Genetics and Molecular Biology (miscellaneous); Computer Science Applications; Drug Discovery; Modeling and Simulation"
778;59522;Current Therapeutics;journal;0311905X;;-;5;1;0;0;0;0;0;0.00;Australia;ADIS Press;1976-1988, 1992, 1994, 1996-2002;Pharmacology
779;21100860941;Expert Review of Precision Medicine and Drug Development;journal;23808993;;-;6;39;52;3175;52;41;1.27;81.41;United Kingdom;Taylor and Francis Ltd.;2016, 2018-ongoing;"Drug Discovery; Genetics; Molecular Medicine; Pharmacology"
780;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;;-;8;29;0;450;0;0;0;15.52;India;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-ongoing;"Pathology and Forensic Medicine; Toxicology"
781;21100820896;Journal of Advanced Pharmacy Education and Research;journal;22493379;;-;2;103;0;2703;0;0;0;26.24;India;Society of Pharmaceutical Education & Research [SPER];2017-ongoing;"Education; Pharmaceutical Science; Pharmacy"
782;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;;-;17;382;916;9132;399;908;0.43;23.91;Argentina;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-ongoing;"Drug Discovery; Pharmaceutical Science"
783;21100858119;Pharmaceutical Sciences Asia;journal;25868195, 25868470;;-;1;21;0;639;0;0;0;30.43;Thailand;Mahidol University - Faculty of Pharmacy;2017-ongoing;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
784;21100830708;Toxics;journal;23056304;;-;12;43;81;2170;132;77;1.65;50.47;Switzerland;MDPI AG;2017-ongoing;"Chemical Health and Safety; Health, Toxicology and Mutagenesis; Toxicology"
